The present invention relates to a method and apparatus for dressing a wound and a method for manufacturing a wound dressing. In particular, but not exclusively, the present invention relates to a wound dressing useable during topical negative pressure (TNP) therapy in which the wound dressing itself acts as a waste canister to collect and store wound exudate removed from a wound site.
There is much prior art available relating to the provision of apparatus arid methods of use thereof for the application of topical negative pressure (TNP) therapy to wounds together with other therapeutic processes intended to enhance the effects of the TNP therapy. Examples of such prior art include those listed and briefly described below.
TNP therapy assists in the closure and healing of wounds by reducing tissue oedema; encouraging blood flow and granulation of tissue; removing excess exudates and may reduce bacterial load and thus, infection to the wound. Furthermore, TNP therapy permits less outside disturbance of the wound and promotes more rapid healing.
In International patent application, WO 2004/037334, apparatus, a wound dressing and a method for aspirating, irrigating and cleansing wounds are described. In very general terms, the application describes the treatment of a wound by the application of TNP therapy for aspirating the wound together with the further provision of additional fluid for irrigating and/or cleansing the wound, which fluid, comprising both wound exudates and irrigation fluid, is then drawn off by the aspiration means and circulated through means for separating the beneficial materials therein from deleterious materials. The materials which are beneficial to wound healing are recirculated through the wound dressing and those materials deleterious to wound healing are discarded to a waste collection bag or vessel.
In International patent application, WO 2005/04670, apparatus, a wound dressing and a method for cleansing a wound using aspiration, irrigation and cleansing wounds are described. Again, in very general terms, the invention described in this document utilizes similar apparatus to that in WO 2004/037334 with regard to the aspiration, irrigation and cleansing of the wound, however, it further includes the important additional step of providing heating means to control the temperature of that beneficial material being returned to the wound site/dressing so that it is at an optimum temperature, for example, to have the most efficacious therapeutic effect on the wound.
In International patent application, WO 2005/105180, apparatus and a method for the aspiration, irrigation and/or cleansing of wounds are described. Again, in very general terms, this document describes similar apparatus to the two previously mentioned documents hereinabove but with the additional step of providing means for the supply and application of physiologically active agents to the wound site/dressing to promote wound healing.
The content of the above-noted references is included herein by reference.
However, the above described apparatus and methods are generally only applicable to a patient when hospitalised as the apparatus used is complex, needing people having specialist knowledge in how to operate and maintain the apparatus, and also relatively heavy and bulky, not being adapted for easy mobility outside of a hospital environment by a patient, for example.
Some patients having relatively less severe wounds which do not require continuous hospitalisation, for example, but whom nevertheless would benefit from the prolonged application of TNP therapy, could be treated at home or at work subject to the availability of an easily portable and maintainable TNP therapy apparatus. To this end GB-A-2 307 180 describes a portable TNP therapy unit which may be carried by a patient and clipped to belt or harness. A negative pressure can thus be applied at a wound site.
During TNP therapy a portable or non-portable therapy unit generates a negative pressure at a wound site. As fluid, including air as well as wound exudate material is removed from the wound site this must be collected in some manner remote from the wound site. With prior known therapy units ‘the collection and storage of wound exudate material is typically carried out by a waste canister connected to a pump unit of the therapy unit. The use of a canister, however, can result in the therapy unit apparatus itself being quite bulky and expensive to manufacture. Also replacing a canister or a bag in a canister in which wound exudate is collected can be a time consuming and relatively unhygienic process.
Prior known therapy units also tend to include a pump which is used to generate the negative pressure. Such pumps can be costly to manufacture and are relatively heavy.
WO 2007/030601, which is incorporated herein by reference discloses a self-contained wound dressing with a micro pump. The pump for drawing wound fluid into a vacuum zone is included in a wound dressing itself. Nevertheless wound exudate from the dressing can only be removed via a complex series of steps. The exudate removal process is also prone to contamination since once an absorbent layer is fully saturated with wound exudate an access door must be opened in the wound dressing so that the absorbent layer and micro pump can be removed. It will be appreciated that such exudate removal and pump removal can be time consuming and can lead to cross contamination between users. A further problem is that the wound dressing is prone to over expansion and rupture.
It is an aim of the present invention to at least partly mitigate the above-mentioned problems.
It is an aim of certain embodiments of the present invention to provide a method for providing negative pressure at a wound site to aid in wound closure and healing in which wound exudate drawn from a wound site during the therapy is collected and stored in a wound dressing.
It is an aim of certain embodiments of the present invention to provide a wound dressing which is able to be placed over a wound site and which includes an integrated pump to generate negative pressure at that wound site. Also for certain embodiments the wound dressing can collect any wound exudate.
According to a first aspect of the present invention there is provided apparatus for dressing a wound, comprising:
According to a second aspect of the present invention there is provided a method of applying topical negative pressure (TNP) at a wound site, comprising the steps of:
Certain embodiments of the present invention provide the advantage that a disposable wound dressing can be fixed over a wound site and can simultaneously be used to provide negative pressure at the wound site and collect and store wound exudate.
Certain embodiments of the present invention provide the advantage that a separate therapy unit is not required to generate negative pressure at a wound site and collect and store any wound exudate. Rather a wound dressing can carry out both a pumping and wound exudate collecting process. The wound dressing may then be a one use item which can be disposed of subsequent to use. This reduces a risk of contamination.
Certain embodiments of the present invention provide the advantage that a wound dressing can be used to collect wound exudate generated during a negative pressure therapy process. A pump remote from the wound dressing can be connected to the wound dressing and reused whilst the wound dressing itself is used to collect wound exudate and may then be disposed of after use.
Embodiments of the present invention will now be described hereinafter, by way of example only, with reference to the accompanying drawings in which:
In the drawings like reference numerals refer to like parts.
The wound dressing 100 can be located over a wound site to be treated. The dressing 100 forms a sealed cavity over the wound site. Optionally wound packer can be used within a wound cavity below the dressing. Aptly the packer material can be a gauze or reticulated PU foam material.
It is envisaged that the negative pressure range for the apparatus embodying the present invention may be between about −50 mmHg and −200 mmHg (note that these pressures are relative to normal ambient atmospheric pressure thus, −200 mmHg would be about 560 mmHg in practical terms). Aptly the pressure range may be between about −75 mmHg and −150 mmHg. Alternatively a pressure range of up to −75 mmHg, up to −80 mmHg or over −80 mmHg can be used. Also aptly a pressure range of below −75 mmHg could be used. Alternatively a pressure range of over −100 mmHg could be used or over −150 mmHg.
As illustrated in
An optional layer 105 of porous material such as a foam layer or the like is located above the wound contact layer. This porous layer allows transmission of fluid including liquid and gas away from a wound site into upper layers of the wound dressing, The layer 105 also helps distribute pressure generated by a pump, mentioned in more detail below, so that a whole wound site sees an equalised negative pressure. Reticulated foam or a non-woven material which might be natural or synthetic can be used as the porous material of the porous layer 105.
A layer 110 of absorbent material is provided above the transmission layer 105 or where no lower transmission layer is used on the wound contact layer or where no transmission layer 105 or wound contact layer 102 are used the absorbent layer lower surface forms the wound contact layer. The absorbent material which may be a foam or non-woven natural or synthetic material and which may optionally include or be super-absorbent material forms a reservoir for fluid, particularly liquid, removed from the wound site. The material of the absorbent layer also prevents liquid collected in the wound dressing from flowing in a sloshing manner. The absorbent layer 130 also helps distribute fluid throughout the layer via a wicking action so that fluid is drawn from the wound site and stored throughout the absorbent layer. This prevents agglomeration in areas of the absorbent layer. Since in use the absorbent layer experiences negative pressures the material of the absorbent layer is chosen to absorb liquid under such circumstances. Superabsorber material is an example of such a material. Non superabsorber material can be utilised however even where significant negative pressures are envisaged. The material of the absorbent layer does not need to be hydrophilic. Aptly a material with connective open voids can be used. Aptly a material is used that can resist the compressive force of the negative pressure e.g. precompressed FT11M foam manufactured by Foam Techniques. Aptly the absorbent material is selected so that fluid is prevented from draining back out when the dressing is removed. It is to be noted that if a superabsorber is used such a material is able to expand against the compressive force of the negative pressure.
A further optional layer 112 of porous material such as a foam layer or the like is located above the absorbent layer 110. This porous layer allows transmission of fluid including liquid and gas away from a wound site into upper layers of the wound dressing. The layer 112 also helps distribute pressure generated by a pump, mentioned in more detail below, so that a whole wound site sees an equalised negative pressure. Reticulated foam or a non-woven material which might be natural or synthetic can be used as a porous material of the porous layer 112. The material may the same or different from the previously mentioned layer 105 of porous material.
A filter layer 130 is provided over the absorbent layer 110. The filter layer permits moisture vapour and gas but no liquid through. A suitable material for the filter material of the filter layer 130 is 0.2 micron Gore™ expanded PTFE from the MMT range. Larger pore sizes can also be used but these may require a secondary filter layer to ensure full bioburden containment. As wound fluid contains lipids it is preferable, though not essential, to use an oleophobic filter membrane for example 1.0 micron MMT-332 prior to 0.2 micron MMT-323. This prevents the lipids from blocking the hydrophobic filter.
It will be understood that other types of material could be used for the filter layer. More generally a microporous membrane can be used which is a thin, flat sheet of polymeric material, this contains billions of microscopic pores. Depending upon the membrane chosen these pores can range in size from 0.01 to more than 10 micrometers. Microporous membranes are available in both hydrophilic (water filtering) and hydrophobic (water repellent) forms. Aptly the wound dressing 100 according to certain embodiments of the present invention uses microporous hydrophobic membranes (MHMs). Numerous polymers may be employed to form MHMs. For example, PTFE, polypropylene, PVDF and acrylic copolymer. All of these optional polymers can be treated in order to obtain specific surface characteristics that can be both hydrophobic and oleo phobic. As such these will repel liquids with low surface tensions such as multi-vitamin infusions, lipids, surfactants, oils and organic solvents.
MHMs block liquids whilst allowing air to flow through the membranes. They are also highly efficient air filters eliminating potentially infectious aerosols and particles. A single piece of MHM is well known as an option to replace mechanical valves or vents. Incorporation of MHMs can thus reduce product assembly costs improving profits and costs/benefit ratio to a patient.
The filter layer 130 thus enables gas to be exhausted upwards through the wound dressing. Liquid, particulates and pathogens however are contained in the dressing.
A gas impermeable sealing layer 140 extends across the width of the wound dressing. The sealing layer which may, for example, be a polyurethane film having a pressure sensitive adhesive on both sides is impermeable to gas and this layer thus operates to seal a wound cavity over which the wound dressing is placed. In this way an effective chamber is made beneath the sealing layer and between the sealing layer and a wound site where a negative pressure can be established. The sealing layer 140 is sealed to the filter layer 130. For example via adhesive or welding techniques. Gas leaving the dressing thus passes through the filter layer and sealing layer.
Aptly the material of the sealing layer can have a high moisture vapour permeability for example Elastollan (Trade name) SP9109 manufactured by BASF. A dotted pattern spread acrylic adhesive can optionally be used to help improve moisture vapour permeability. An advantage of using a high moisture vapour permeability material as the sealing layer 160 is that the fluid handling capacity of the dressing may be increased significantly by the action of moisture transpiring through the film and dispersing into the atmosphere. Advantageously, transpiration rates can be easily achieved of the order of 3000 grams/centimetre square/24 hours as a result of the high humidity achieved in the dressing and intimate contact of material achieved during use of the apparatus at a negative pressure of up to 250 mmHg below atmospheric pressure.
As illustrated in
A layer 150 of porous material such as a foam layer or the like is located above the sealing layer 140. This porous layer allows transmission of fluid including liquid and gas away from a wound site. The layer 150 also helps distribute pressure generated by a pump, mentioned in more detail below, so that a whole wound site sees an equalised negative pressure. Reticulated foam or a non-woven material which might be natural or synthetic can be used as the porous material of the layer 150. The material may be the same or different from the material of the underlying layers 105, 112.
A cover layer 160 covers the absorbent layer of the wound dressing 100. The cover layer which, for example, may be a polyurethane film acts as a bacterial barrier and helps hold in liquid to stop fouling. The cover layer also provides integrity for the dressing and is impermeable to moisture vapour and gas. The cover layer helps hold the wound dressing together thus providing structural integrity. An upper surface 171 also presents a bacteria free non soiling surface. As an alternative the material of the cover layer can have a high moisture vapour permeability, for example Elastollan (Trade name) SP9109 manufactured by BASF. A dotted pattern spread acrylic adhesive can optionally be used to help improve moisture vapour permeability. An advantage of using a high moisture vapour permeability material as the cover layer 160 is that the fluid handling capacity of the dressing may be increased significantly by the action of moisture transpiring through the film and dispersing into the atmosphere. Advantageously, transpiration rates can be easily achieved of the order of 3000 grams/centimetre square/24 hours as a result of the high humidity achieved in the dressing and intimate contact of material achieved during use of the apparatus at a negative pressure of up to 250 mmHg below atmospheric pressure.
A single aperture 165 farmed as a single hole or close arrangement of holes is formed in a central region of the upper cover layer. The aperture 165 is in fluid communication with an inlet to a pump 170 which is mounted on the upper surface 171 of the cover layer. In operation the pump 170 pumps fluid through the wound dressing from a wound site below the wound contact layer 102 upwards through the first transmission layer 105, absorbent layer 110, further transmission layer 112, filter layer 130, sealing layer 140, and further transmission layer 150.
Turning to
It will be understood that according to embodiments of the present invention the wound contact layer is optional. This layer is, if used, porous to water and faces an underlying wound site. A lower porous layer 105 such as a reticulated PU foam layer is used to distribute gas and fluid removal such that all areas of a wound are subjected to equal pressure. The sealing layer together with the filter layer forms a substantially liquid tight seal over the wound. Thus as the pump 170 pumps a negative pressure is generated below the sealing layer. This negative pressure is thus experienced at the target wound site. Fluid including air and wound exudate is drawn through the wound contact layer and reticulated foam layer 105. The wound exudate drawn through the lower layers of the wound dressing is dissipated and absorbed into the absorbent layer where it is collected and stored. Air and moisture vapour is drawn upwards through the wound dressing through the intermediate transmission layer 112 and through the filter layer and sealing layer. The filter layer and sealing layer are secured together so as to prevent upward movement through the wound dressing of anything other than moisture vapour and air. This air and moisture vapour is drawn upwards by the pump 170 into the fluid inlet 300. The pump exhausts the fluid as air and moisture vapour through a fluid exit (not shown).
It is to be noted that the upper transmission layer 150 and cover layer 160 are optional. Their use is helpful during multi orientation use when portions of the filter layer might otherwise become occluded. When a separate cover layer 160 is not utilised the sealing layer also performs the extra function of covering the dressing and will thus additionally act as a cover layer.
It will be appreciated by those skilled in the art that rather than have a cover layer overlying the filter layer the cover layer may itself be overlain by a filter layer. The cover layer may thus be the outermost layer of the wound dressing or the filter layer may be the outermost layer of the wound dressing. Further outer layers (not shown) may optionally be used so long as they are gas and water vapour permeable.
As still further options the dressing can contain anti-microbial e.g. nanocrystalline silver agents on the wound contact layer and/or silver sulphur diazine in the absorbent layer. These may be used separately or together. These respectively kill micro-organisms in the wound and micro-organisms in the absorption matrix. As a still further option other active components, for example, pain suppressants, such as ibuprofen, may be included. Also agents which enhance cell activity, such as growth factors or that inhibit enzymes, such as matrix metalloproteinase inhibitors, such as tissue inhibitors of metalloproteinase (TIMPS) or zinc chelators could be utilised. As a still further option odour trapping elements such as activated carbon, cyclodextrine, zealite or the like may be included in the absorbent layer or as a still further layer above the filter layer.
A transmission layer 105 is duly located in the dished central region 400 of the wound contact layer. The foam layer includes a substantially rectangular base region 401 together with an array of upstanding columns 402. As illustrated in
The absorbent layer 110 is located above the transmission layer 105. The absorbent layer 110 is a layer of absorbent material and includes through holes 403 formed in a substantially rectangular block 404 of absorbent material. The through holes are set out in an 8×8 array to coincide with the upstanding columns 402 in the underlying transmission layer. It will be appreciated that the number and pattern of through bores 403 is selected to tally with the shape and number and arrangement of the columns.
The intermediate transmission layer 112 is a substantially rectangular base section 405 of porous material such as reticulated foam with an array of columns 406 extending downwardly from a lower surface of the base 405. The columns 406 coincide with locations of the through bores 403 in the absorbent layer. It will be appreciated that the columns 406 of the intermediate transmission layer 112 may be integrally formed with the base portion 405 of the transmission layer or may be secured in some fashion thereto. The height of the columns 402,406 of the lower and intermediate transmission layers respectively is such that an upper contact surface of the columns 402 of the lower transmission layer and a lower contact surface of the columns 406 of the intermediate transmission layer contact when the wound dressing is put together. These thus provide fluid transmission paths through the absorber layer so that fluid, including air and wound exudate and liquid, is drawn from the lower region upwardly through the absorbent layer when the pump 170 is operating.
A rectangular layer of filter material 130 is located above the upper surface of the base section 405 of the intermediate transmission layer. The filter layer blocks movement therethrough of liquid. The filter layer is aptly a 0.2 micron Gore™ expanded PTFE sheet.
A sealing layer 140 is located over the filter layer 130. The sealing layer has a border region and a generally concave central region 407. The underside of the sealing layer 140 is thus recessed. An array of apertures set out in a 5×5 grid array is made through the sealing layer 140. The sealing layer away from the apertures is gas and fluid tight. If a material having a high moisture vapour permeability is optionally used then the sealing layer will of course be permeable to moisture vapour. Fluid, including liquid and gas, can of course penetrate through the perforations. The filter layer 130 which is secured on the underside of the sealing layer, however, prevents liquid penetration through the apertures and to an extent prevents penetration of air through the apertures. Moisture vapour can penetrate through the apertures.
An upper transmission layer formed as a sheet of reticulated foam is located over the central region of the upper surface of the sealing layer 140. The upper transmission layer acts as a manifold and diffuser to help spread the negative pressure generated by the pump 170.
A cover layer 160 is located over the sealing layer and upper transmission layer 150. The cover layer has a border region 200 and a central raised region 201. The underside of the cover layer thus presents a central dished region to receive the upper transmission layer, raised central region of the sealing layer and the filter layer, intermediate transmission layer, absorbent layer and lower transmission layer. A central aperture 165 is made in the centre of the upper surface of the cover layer. The central aperture 165 is located to coincide with a fluid inlet 300 of the pump 170. Thus in use when a pump 170 is in use a negative pressure is generated under the cover 160. This negative pressure is distributed throughout the wound dressing and at a target wound site located under the wound contact layer. As the negative pressure is established and maintained wound exudate and air is drawn upwards away from the wound site through the wound dressing. Liquid and air is drawn upwards through the wound contact layer into the base of the lower transmission layer 105 and upwards through the connecting columns in the lower transmission layer and intermediate transmission layer. It will be appreciated of course that columns having a height sufficient to bridge the whole of the absorbent layer could be provided on either the upper surface of the lower transmission layer 105 or the lower surface of the intermediate transmission layer 112. Alternatively the apertures 403 in the absorbent layer may be filled with transmissive material such as foam cylinders when the wound dressing is manufactured. Any wound exudate being drawn upward through the wound dressing is dissipated outwardly from the absorbent material in the aperture regions of the absorbent layer. The liquid is thus collected and stored in the absorbent layer. Air and moisture vapour carries on upwards through the filter layer 130 and sealing layer 140 and is evacuated by the pump 170.
It will be appreciated that according to certain embodiments of the present invention fluid communication paths through which fluid can be transmitted from the lower transmission layer to the intermediate transmission layer can be made by pinching together peripheral regions of the lower and intermediate regions. Fluid transmission would thus proceed around the peripheral edges of the wound dressing. Such fluid paths may replace the fluid paths formed by the columns passing through apertures in the absorbent layer or may alternatively take the place of such passageways. This would maximise the quantity of absorber material in the layer 110 in the resultant wound dressing.
It is to be noted that according to certain other embodiments of the present invention a remote pump may be mounted to a border region of the wound dressing rather than onto the top surface. In such case tubes may be connected directly to the pump. Subsequent to a single use the wound dressing and pump may thus be discarded. As an option the tubes may be provided with a click fit connector or other easy fit connector which can be connected to corresponding mating connectors joined via corresponding tubes to a remote pump. In this way a remote pump may be reused whilst the wound dressing itself including connecting tubes and connectors is disposable after a single use.
It will be appreciated that alternatively the tubes could be provided by a single dual lumen tube. As a still further alternative the tubes may be provided by a single continuous looped tube, the tube then passing through pinch rollers for a peristaltic pump.
It will be understood that for embodiments of the present invention which include a pump mounted on the cover layer or on a peripheral border area of the dressing an integral power source and control circuitry can be included. Alternatively the power source can be external to the pump and remotely mounted. A remote power source and/or control circuitry improves the disposability of the dressing and permits battery recharge if spare batteries are used.
It is to be noted that in use the dressing may be used “up-side down”, at an angle or vertical. References to upper and lower are thus used for explanation purposes only.
Where a separate cover layer and sealing layer are utilised such layers may be manufactured from the same or different materials.
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of the words, for example “comprising” and “comprises”, means “including but not limited to”, and is not intended to (and does not) exclude other moieties, additives, components, integers or steps.
Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith.
Number | Date | Country | Kind |
---|---|---|---|
0722820 | Nov 2007 | GB | national |
0817020 | Sep 2008 | GB | national |
This application is a divisional of U.S. application Ser. No. 14/259,026, filed Apr. 22, 2014, which is a continuation of U.S. application Ser. No. 12/744,277, filed Sep. 20, 2010, which is the U.S. National Phase of PCT International Application No. PCT/GB2008/051090 filed on Nov. 20, 2008, designating the United States and published on May 28, 2009 as WO 2009/066106, which claims priority to Great Britain Patent Application No. 0722820.8, filed Nov. 21, 2007, and Great Britain Patent Application No. 0817020.1, filed Sep. 17, 2008. The disclosure of these prior applications are incorporated by reference in their entireties and should be considered a part of this specification.
Number | Name | Date | Kind |
---|---|---|---|
695270 | Beringer | Mar 1902 | A |
1480562 | Mock | Jan 1924 | A |
2280915 | Johnson | Apr 1942 | A |
2367690 | Purdy | Jul 1943 | A |
2568933 | Robbins | Sep 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Aug 1955 | A |
3115138 | McElvenny et al. | Dec 1963 | A |
3367332 | Groves | Feb 1968 | A |
3572340 | Lloyd et al. | Mar 1971 | A |
3874387 | Barbieri | Apr 1975 | A |
3972328 | Chen | Aug 1976 | A |
3993080 | Loseff | Nov 1976 | A |
4029598 | Neisius et al. | Jun 1977 | A |
RE29319 | Nordby et al. | Jul 1977 | E |
4102342 | Akiyama et al. | Jul 1978 | A |
4112947 | Nehring | Sep 1978 | A |
4117551 | Books et al. | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4217894 | Franetzki | Aug 1980 | A |
4219019 | Coates | Aug 1980 | A |
4224941 | Stivala | Sep 1980 | A |
4224945 | Cohen | Sep 1980 | A |
4316466 | Babb | Feb 1982 | A |
4382441 | Svedman | May 1983 | A |
4398910 | Blake et al. | Aug 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4466431 | Tharrat et al. | Aug 1984 | A |
4529402 | Weilbacher et al. | Jul 1985 | A |
4534356 | Papadakis | Aug 1985 | A |
4538920 | Drake et al. | Sep 1985 | A |
4569674 | Phillips | Feb 1986 | A |
4573965 | Russo | Mar 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
4624656 | Clark et al. | Nov 1986 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4655766 | Theeuwes et al. | Apr 1987 | A |
4681562 | Beck et al. | Jul 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4728499 | Fehder | Mar 1988 | A |
4753536 | Spehar et al. | Jun 1988 | A |
4767026 | Keller | Aug 1988 | A |
4767943 | Adler et al. | Aug 1988 | A |
4771919 | Ernst | Sep 1988 | A |
4778446 | Jensen | Oct 1988 | A |
4792328 | Beck et al. | Dec 1988 | A |
4813942 | Alvarez | Mar 1989 | A |
4826494 | Richmond et al. | May 1989 | A |
4828546 | McNeil et al. | May 1989 | A |
4872450 | Austad | Oct 1989 | A |
4921488 | Maitz et al. | May 1990 | A |
4936834 | Beck et al. | Jun 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4972829 | Knerr | Nov 1990 | A |
4979944 | Luzsicza | Dec 1990 | A |
4994022 | Steffler et al. | Feb 1991 | A |
5010115 | Grisoni | Apr 1991 | A |
5055195 | Trasch et al. | Oct 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5056510 | Gilman | Oct 1991 | A |
5060642 | Gilman | Oct 1991 | A |
5061258 | Martz | Oct 1991 | A |
5064653 | Sessions et al. | Nov 1991 | A |
5073172 | Fell | Dec 1991 | A |
5080493 | McKown et al. | Jan 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5152757 | Eriksson | Oct 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5181905 | Flam | Jan 1993 | A |
5215519 | Shettigar | Jun 1993 | A |
5222714 | Morinigo et al. | Jun 1993 | A |
5234419 | Bryant et al. | Aug 1993 | A |
5238732 | Krishnan | Aug 1993 | A |
5249709 | Duckworth et al. | Oct 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5266326 | Barry et al. | Nov 1993 | A |
5266928 | Johnson | Nov 1993 | A |
5279608 | Cherif Cheikh | Jan 1994 | A |
5291822 | Alsobrooks et al. | Mar 1994 | A |
5328614 | Matsumura | Jul 1994 | A |
5333760 | Simmen et al. | Aug 1994 | A |
5349896 | Connelly et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5380280 | Peterson | Jan 1995 | A |
D357743 | Bilitz et al. | Apr 1995 | S |
5417743 | Dauber | May 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5445604 | Lang | Aug 1995 | A |
5449003 | Sugimura | Sep 1995 | A |
5449347 | Preen et al. | Sep 1995 | A |
5456745 | Rorefer et al. | Oct 1995 | A |
5466229 | Elson | Nov 1995 | A |
5489280 | Russell | Feb 1996 | A |
5498338 | Kruger et al. | Mar 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5536233 | Khouri | Jul 1996 | A |
5549584 | Gross | Aug 1996 | A |
5582596 | Fukunaga et al. | Dec 1996 | A |
5583114 | Barrows et al. | Dec 1996 | A |
5609271 | Keller et al. | Mar 1997 | A |
5612050 | Rowe et al. | Mar 1997 | A |
5624423 | Anjur et al. | Apr 1997 | A |
5632731 | Patel | May 1997 | A |
5634391 | Eady | Jun 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5643189 | Masini | Jul 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5660823 | Chakrabarti et al. | Aug 1997 | A |
5662583 | Khouri | Sep 1997 | A |
5676525 | Berner et al. | Oct 1997 | A |
5676634 | Khouri | Oct 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5687633 | Eady | Nov 1997 | A |
5693013 | Geuder | Dec 1997 | A |
5695445 | Khouri | Dec 1997 | A |
5701917 | Khouri | Dec 1997 | A |
5707499 | Joshi et al. | Jan 1998 | A |
5717030 | Dunn et al. | Feb 1998 | A |
5730587 | Snyder et al. | Mar 1998 | A |
5733337 | Carr et al. | Mar 1998 | A |
5743170 | Forman et al. | Apr 1998 | A |
5747064 | Burnett et al. | May 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5769608 | Seale | Jun 1998 | A |
5776098 | Silver et al. | Jul 1998 | A |
5776193 | Kwan et al. | Jul 1998 | A |
5779657 | Daneshvar | Jul 1998 | A |
5785508 | Bolt | Jul 1998 | A |
5785688 | Joshi et al. | Jul 1998 | A |
5817145 | Augustine et al. | Oct 1998 | A |
5830496 | Freeman | Nov 1998 | A |
5833646 | Masini | Nov 1998 | A |
5834007 | Kubota | Nov 1998 | A |
5843011 | Lucas | Dec 1998 | A |
5852126 | Barnard et al. | Dec 1998 | A |
5863184 | Juterbock et al. | Jan 1999 | A |
5868933 | Patrick et al. | Feb 1999 | A |
5874500 | Rhee et al. | Feb 1999 | A |
5876611 | Shettigar | Mar 1999 | A |
5897296 | Yamamoto et al. | Apr 1999 | A |
5902256 | Benaron | May 1999 | A |
5902260 | Gilman et al. | May 1999 | A |
5904659 | Duarte | May 1999 | A |
5928265 | Fleischmann | Jul 1999 | A |
5941840 | Court et al. | Aug 1999 | A |
5945115 | Dunn et al. | Aug 1999 | A |
5950523 | Reynolds | Sep 1999 | A |
5962010 | Greff et al. | Oct 1999 | A |
5964723 | Augustine | Oct 1999 | A |
5998472 | Berger et al. | Dec 1999 | A |
6010527 | Augustine et al. | Jan 2000 | A |
6013097 | Augustine et al. | Jan 2000 | A |
6068588 | Goldowsky | May 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6080685 | Eady | Jun 2000 | A |
6093160 | Augustine et al. | Jul 2000 | A |
6102680 | Fraser et al. | Aug 2000 | A |
6103951 | Freeman | Aug 2000 | A |
6110197 | Augustine et al. | Aug 2000 | A |
6117111 | Fleischmann | Sep 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6138550 | Fingar, Jr. | Oct 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6143352 | Clark et al. | Nov 2000 | A |
6145430 | Able et al. | Nov 2000 | A |
6158327 | Huss | Dec 2000 | A |
6162194 | Shipp | Dec 2000 | A |
6165201 | Sawhney et al. | Dec 2000 | A |
6168788 | Wortham | Jan 2001 | B1 |
6168800 | Dobos et al. | Jan 2001 | B1 |
6176307 | Danos et al. | Jan 2001 | B1 |
6183438 | Berguer | Feb 2001 | B1 |
6214332 | Askill et al. | Apr 2001 | B1 |
6225523 | Masini | May 2001 | B1 |
6227825 | Vay | May 2001 | B1 |
6230609 | Fingar | May 2001 | B1 |
6231310 | Tojo et al. | May 2001 | B1 |
6248084 | Augustine et al. | Jun 2001 | B1 |
6249198 | Clark et al. | Jun 2001 | B1 |
6252129 | Coffee | Jun 2001 | B1 |
6254567 | Treu et al. | Jul 2001 | B1 |
6255552 | Cummings et al. | Jul 2001 | B1 |
6257847 | Silver et al. | Jul 2001 | B1 |
6261276 | Reitsma | Jul 2001 | B1 |
6261283 | Morgan et al. | Jul 2001 | B1 |
6267740 | Augustine et al. | Jul 2001 | B1 |
6287521 | Quay et al. | Sep 2001 | B1 |
6291050 | Cree et al. | Sep 2001 | B1 |
6293917 | Augustine et al. | Sep 2001 | B1 |
6323568 | Zabar | Nov 2001 | B1 |
6327960 | Heimueller et al. | Dec 2001 | B1 |
6343539 | Du | Feb 2002 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6383163 | Kelly et al. | May 2002 | B1 |
6391294 | Dettmar et al. | May 2002 | B1 |
6398761 | Bills et al. | Jun 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6402724 | Smith et al. | Jun 2002 | B1 |
6413057 | Hong et al. | Jul 2002 | B1 |
6440167 | Shimizu | Aug 2002 | B2 |
6447802 | Sessions et al. | Sep 2002 | B2 |
6450773 | Upton | Sep 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6465708 | Augustine | Oct 2002 | B1 |
6468295 | Augustine et al. | Oct 2002 | B2 |
6471685 | Johnson | Oct 2002 | B1 |
6471982 | Lydon et al. | Oct 2002 | B1 |
6481986 | Silver et al. | Nov 2002 | B1 |
6486285 | Fujita | Nov 2002 | B2 |
6491684 | Joshi et al. | Dec 2002 | B1 |
6495127 | Wallace et al. | Dec 2002 | B1 |
6500112 | Khouri | Dec 2002 | B1 |
6509031 | Miller et al. | Jan 2003 | B1 |
6521251 | Askill et al. | Feb 2003 | B2 |
6540490 | Lilie | Apr 2003 | B1 |
6547467 | Quintero | Apr 2003 | B2 |
6547756 | Greter et al. | Apr 2003 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6575940 | Levinson et al. | Jun 2003 | B1 |
6580012 | Augustine et al. | Jun 2003 | B1 |
6589028 | Eckerbom et al. | Jul 2003 | B1 |
6596704 | Court et al. | Jul 2003 | B1 |
6599262 | Masini | Jul 2003 | B1 |
6607495 | Skalak et al. | Aug 2003 | B1 |
6626891 | Ohmstede | Sep 2003 | B2 |
6627216 | Brandt et al. | Sep 2003 | B2 |
6629774 | Guruendeman | Oct 2003 | B1 |
6638035 | Puff | Oct 2003 | B1 |
6638270 | Johnson | Oct 2003 | B2 |
6648862 | Watson | Nov 2003 | B2 |
6655257 | Meyer | Dec 2003 | B1 |
6673028 | Argenta et al. | Jan 2004 | B1 |
6673036 | Britto | Jan 2004 | B1 |
6676610 | Morton et al. | Jan 2004 | B2 |
6676631 | Greter | Jan 2004 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6695824 | Howard et al. | Feb 2004 | B2 |
6699213 | Annis et al. | Mar 2004 | B1 |
6730299 | Tayot et al. | May 2004 | B1 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6767334 | Randolph | Jul 2004 | B1 |
6775807 | Lowther et al. | Aug 2004 | B2 |
6787682 | Gilman | Sep 2004 | B2 |
6790438 | Constancis et al. | Sep 2004 | B1 |
6800074 | Henley et al. | Oct 2004 | B2 |
6808517 | Greter et al. | Oct 2004 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6823905 | Smith et al. | Nov 2004 | B1 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6856821 | Johnson | Feb 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6942633 | Odland | Sep 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6960179 | Gura | Nov 2005 | B2 |
6977323 | Swenson | Dec 2005 | B1 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
6987209 | Augustine et al. | Jan 2006 | B2 |
6994702 | Johnson | Feb 2006 | B1 |
6997897 | Silver et al. | Feb 2006 | B1 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7008400 | Silver et al. | Mar 2006 | B2 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7041057 | Faupel et al. | May 2006 | B1 |
7067709 | Murata et al. | Jun 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7087806 | Scheinberg et al. | Aug 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7122046 | Augustine et al. | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7129210 | Lowinger et al. | Oct 2006 | B2 |
7141714 | Nielsen | Nov 2006 | B2 |
7151348 | Ueda et al. | Dec 2006 | B1 |
7195624 | Lockwood | Mar 2007 | B2 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7214202 | Vogel et al. | May 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
7220889 | Sigurjonsson et al. | May 2007 | B2 |
7238850 | Shimanuki | Jul 2007 | B2 |
7255681 | Silver et al. | Aug 2007 | B1 |
7273054 | Heaton et al. | Sep 2007 | B2 |
7279612 | Heaton et al. | Oct 2007 | B1 |
7303757 | Schankereli et al. | Dec 2007 | B2 |
7316672 | Hunt et al. | Jan 2008 | B1 |
7335809 | Riesinger | Feb 2008 | B2 |
7338482 | Lockwood et al. | Mar 2008 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7381211 | Zamierowski | Jun 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7438705 | Karpowicz et al. | Oct 2008 | B2 |
7447327 | Kitamura et al. | Nov 2008 | B2 |
7470830 | Sigurjonsson et al. | Dec 2008 | B2 |
7485112 | Karpowicz et al. | Feb 2009 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7503910 | Adahan | Mar 2009 | B2 |
7507870 | Nielsen et al. | Mar 2009 | B2 |
7524286 | Johnson | Apr 2009 | B2 |
7524315 | Blott et al. | Apr 2009 | B2 |
7534240 | Johnson | May 2009 | B1 |
7534927 | Lockwood | May 2009 | B2 |
7553306 | Hunt et al. | Jun 2009 | B1 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7601129 | Aali | Oct 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7611500 | Lina et al. | Nov 2009 | B1 |
7612247 | Oyaski | Nov 2009 | B2 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7622629 | Aail | Nov 2009 | B2 |
D605775 | Koch et al. | Dec 2009 | S |
7625362 | Boehringer et al. | Dec 2009 | B2 |
D608007 | Arbesman et al. | Jan 2010 | S |
7645253 | Gura et al. | Jan 2010 | B2 |
7645269 | Zamierowski | Jan 2010 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7678090 | Risk, Jr. | Mar 2010 | B2 |
7687678 | Jacobs | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7699830 | Martin | Apr 2010 | B2 |
7700819 | Ambrosio et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7717313 | Criscuolo et al. | May 2010 | B2 |
7718249 | Russell et al. | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
7731702 | Bybordi et al. | Jun 2010 | B2 |
7745681 | Ferguson | Jun 2010 | B1 |
7749531 | Booher | Jul 2010 | B2 |
7753894 | Blott et al. | Jul 2010 | B2 |
7754936 | Heaton et al. | Jul 2010 | B2 |
7754937 | Boehringer et al. | Jul 2010 | B2 |
7758514 | Grigoryants et al. | Jul 2010 | B2 |
7758554 | Lina et al. | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759538 | Fleischmann | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7763000 | Risk, Jr. et al. | Jul 2010 | B2 |
7763769 | Johnson et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7790945 | Watson, Jr. | Sep 2010 | B1 |
7790946 | Mulligan | Sep 2010 | B2 |
7794438 | Henley et al. | Sep 2010 | B2 |
7794450 | Blott et al. | Sep 2010 | B2 |
7803980 | Griffiths et al. | Sep 2010 | B2 |
7811269 | Boynton et al. | Oct 2010 | B2 |
7815616 | Boehringer et al. | Oct 2010 | B2 |
7816577 | Aali | Oct 2010 | B2 |
7828782 | Suzuki | Nov 2010 | B2 |
7838716 | de Luis et al. | Nov 2010 | B2 |
7838717 | Haggstrom et al. | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7857806 | Karpowicz et al. | Dec 2010 | B2 |
7858838 | Holm et al. | Dec 2010 | B2 |
7862339 | Mulligan | Jan 2011 | B2 |
7862831 | Wang et al. | Jan 2011 | B2 |
7867206 | Lockwood et al. | Jan 2011 | B2 |
7880050 | Robinson et al. | Feb 2011 | B2 |
7884258 | Boehringer et al. | Feb 2011 | B2 |
7886746 | Heaton et al. | Feb 2011 | B2 |
7896823 | Mangrum et al. | Mar 2011 | B2 |
7896856 | Petrosenko et al. | Mar 2011 | B2 |
7896864 | Lockwood et al. | Mar 2011 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7910135 | St. John et al. | Mar 2011 | B2 |
7910791 | Coffey | Mar 2011 | B2 |
7922676 | Daskal et al. | Apr 2011 | B2 |
7922703 | Riesinger | Apr 2011 | B2 |
7927318 | Risk, Jr. et al. | Apr 2011 | B2 |
7931630 | Nishtala et al. | Apr 2011 | B2 |
7942866 | Radl et al. | May 2011 | B2 |
7951100 | Hunt et al. | May 2011 | B2 |
7951124 | Boehringer et al. | May 2011 | B2 |
7959624 | Riesinger | Jun 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
D642594 | Mattson et al. | Aug 2011 | S |
7988680 | Lockwood et al. | Aug 2011 | B2 |
7998125 | Weston | Aug 2011 | B2 |
8007164 | Miyano et al. | Aug 2011 | B2 |
8007257 | Heaton et al. | Aug 2011 | B2 |
8007481 | Schuessler et al. | Aug 2011 | B2 |
8021348 | Risk, Jr. et al. | Sep 2011 | B2 |
8022266 | Boehringer et al. | Sep 2011 | B2 |
8025650 | Anderson et al. | Sep 2011 | B2 |
8034037 | Adams et al. | Oct 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062273 | Weston | Nov 2011 | B2 |
8062331 | Zamierowski | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8084663 | Watson, Jr. | Dec 2011 | B2 |
8092441 | Sugito | Jan 2012 | B2 |
8097272 | Addison | Jan 2012 | B2 |
8100887 | Weston et al. | Jan 2012 | B2 |
8105295 | Blott et al. | Jan 2012 | B2 |
8118794 | Weston et al. | Feb 2012 | B2 |
8119160 | Looney et al. | Feb 2012 | B2 |
8133211 | Cavanaugh, II et al. | Mar 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8158844 | McNeil | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8162909 | Blott et al. | Apr 2012 | B2 |
8168848 | Lockwood et al. | May 2012 | B2 |
8192409 | Hardman et al. | Jun 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8211071 | Mormino et al. | Jul 2012 | B2 |
8212100 | Moore | Jul 2012 | B2 |
8215929 | Shen et al. | Jul 2012 | B2 |
8226942 | Charier et al. | Jul 2012 | B2 |
8235955 | Blott et al. | Aug 2012 | B2 |
8235972 | Adahan | Aug 2012 | B2 |
8241015 | Lillie | Aug 2012 | B2 |
8241261 | Randolph et al. | Aug 2012 | B2 |
8246606 | Stevenson et al. | Aug 2012 | B2 |
8251979 | Malhi | Aug 2012 | B2 |
8257327 | Blott et al. | Sep 2012 | B2 |
8257328 | Augustine et al. | Sep 2012 | B2 |
8273368 | Ambrosio et al. | Sep 2012 | B2 |
8282611 | Weston | Oct 2012 | B2 |
8294586 | Pidgeon et al. | Oct 2012 | B2 |
8303552 | Weston | Nov 2012 | B2 |
8308714 | Weston et al. | Nov 2012 | B2 |
8323264 | Weston et al. | Dec 2012 | B2 |
8338402 | Fry et al. | Dec 2012 | B2 |
8348910 | Blott et al. | Jan 2013 | B2 |
8372049 | Jaeb et al. | Feb 2013 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8382731 | Johannison | Feb 2013 | B2 |
8404921 | Lee et al. | Mar 2013 | B2 |
D679819 | Peron | Apr 2013 | S |
D679820 | Peron | Apr 2013 | S |
8410189 | Carnahan et al. | Apr 2013 | B2 |
8414519 | Hudspeth et al. | Apr 2013 | B2 |
8419696 | Wilkes | Apr 2013 | B2 |
8425478 | Olson | Apr 2013 | B2 |
8444612 | Patel et al. | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8494349 | Gordon | Jul 2013 | B2 |
8529548 | Blott et al. | Sep 2013 | B2 |
8535283 | Heaton et al. | Sep 2013 | B2 |
8535296 | Blott et al. | Sep 2013 | B2 |
8545464 | Weston | Oct 2013 | B2 |
8556871 | Mormino et al. | Oct 2013 | B2 |
8569566 | Blott et al. | Oct 2013 | B2 |
8603074 | Kagan | Dec 2013 | B2 |
8617129 | Hartwell | Dec 2013 | B2 |
8622981 | Hartwell et al. | Jan 2014 | B2 |
8628505 | Weston | Jan 2014 | B2 |
8641691 | Fink | Feb 2014 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8679079 | Heaton et al. | Mar 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8753670 | Delmotte | Jun 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8795243 | Weston | Aug 2014 | B2 |
8795244 | Randolph et al. | Aug 2014 | B2 |
8795635 | Tamarkin et al. | Aug 2014 | B2 |
8795713 | Makower et al. | Aug 2014 | B2 |
8808274 | Hartwell | Aug 2014 | B2 |
8827983 | Braga et al. | Sep 2014 | B2 |
8829263 | Haggstrom et al. | Sep 2014 | B2 |
8834451 | Blott et al. | Sep 2014 | B2 |
8834452 | Hudspeth et al. | Sep 2014 | B2 |
8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
8864748 | Coulthard et al. | Oct 2014 | B2 |
8905985 | Allen et al. | Dec 2014 | B2 |
8915895 | Jaeb et al. | Dec 2014 | B2 |
8945074 | Buan et al. | Feb 2015 | B2 |
8956336 | Haggstrom et al. | Feb 2015 | B2 |
8968773 | Thomas et al. | Mar 2015 | B2 |
8974429 | Gordon et al. | Mar 2015 | B2 |
9028872 | Gaserod et al. | May 2015 | B2 |
9050209 | Coulthard et al. | Jun 2015 | B2 |
9061095 | Adie et al. | Jun 2015 | B2 |
9084845 | Adie et al. | Jul 2015 | B2 |
9127665 | Locke et al. | Sep 2015 | B2 |
9198802 | Robinson et al. | Dec 2015 | B2 |
9211365 | Weston | Dec 2015 | B2 |
9220822 | Hartwell et al. | Dec 2015 | B2 |
9302033 | Riesinger | Apr 2016 | B2 |
9375353 | Vitaris et al. | Jun 2016 | B2 |
9375521 | Hudspeth et al. | Jun 2016 | B2 |
9381283 | Adams et al. | Jul 2016 | B2 |
9414968 | Heagle | Aug 2016 | B2 |
9421133 | Hu et al. | Aug 2016 | B2 |
9452245 | Jaeb et al. | Sep 2016 | B2 |
9452248 | Blott et al. | Sep 2016 | B2 |
9456928 | Haggstrom et al. | Oct 2016 | B2 |
9669138 | Joshi et al. | Jun 2017 | B2 |
9795725 | Joshi et al. | Oct 2017 | B2 |
9844475 | Hartwell | Dec 2017 | B2 |
9956121 | Hartwell | May 2018 | B2 |
10010656 | Jaeb et al. | Jul 2018 | B2 |
10123909 | Hartwell | Nov 2018 | B2 |
10265445 | Weston | Apr 2019 | B2 |
10384041 | Patel et al. | Aug 2019 | B2 |
10391212 | Joshi et al. | Aug 2019 | B2 |
10463773 | Haggstrom et al. | Nov 2019 | B2 |
20010001278 | Drevet | May 2001 | A1 |
20010004082 | Keller et al. | Jun 2001 | A1 |
20010029956 | Argenta | Oct 2001 | A1 |
20010031911 | Khouri | Oct 2001 | A1 |
20010033795 | Humpheries | Oct 2001 | A1 |
20010034499 | Sessions et al. | Oct 2001 | A1 |
20010038799 | Silver et al. | Nov 2001 | A1 |
20010043870 | Song | Nov 2001 | A1 |
20010043913 | Spaans et al. | Nov 2001 | A1 |
20010043943 | Coffey | Nov 2001 | A1 |
20020002209 | Mork | Jan 2002 | A1 |
20020017304 | Heaton et al. | Feb 2002 | A1 |
20020026133 | Augustine et al. | Feb 2002 | A1 |
20020026946 | McKay | Mar 2002 | A1 |
20020038826 | Hurray et al. | Apr 2002 | A1 |
20020082567 | Lockwood et al. | Jun 2002 | A1 |
20020122732 | Oh et al. | Sep 2002 | A1 |
20020122771 | Holland et al. | Sep 2002 | A1 |
20020138036 | Babaev | Sep 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20020145007 | Sawhney et al. | Oct 2002 | A1 |
20020161317 | Risk et al. | Oct 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20020164255 | Burr et al. | Nov 2002 | A1 |
20020183702 | Henley et al. | Dec 2002 | A1 |
20020187182 | Kramer et al. | Dec 2002 | A1 |
20020198490 | Wirt et al. | Dec 2002 | A1 |
20020198503 | Risk, Jr. et al. | Dec 2002 | A1 |
20020198504 | Risk et al. | Dec 2002 | A1 |
20030021775 | Freeman | Jan 2003 | A1 |
20030023286 | Augustine et al. | Jan 2003 | A1 |
20030035743 | Lee et al. | Feb 2003 | A1 |
20030040478 | Drucker et al. | Feb 2003 | A1 |
20030040687 | Boynton et al. | Feb 2003 | A1 |
20030045825 | Etheredge, III | Mar 2003 | A1 |
20030050594 | Zamierowski | Mar 2003 | A1 |
20030069529 | Augustine et al. | Apr 2003 | A1 |
20030069535 | Shalaby | Apr 2003 | A1 |
20030069536 | Greter et al. | Apr 2003 | A1 |
20030069563 | Johnson | Apr 2003 | A1 |
20030095879 | Oh et al. | May 2003 | A1 |
20030099558 | Chang | May 2003 | A1 |
20030108430 | Yoshida et al. | Jun 2003 | A1 |
20030110939 | Able et al. | Jun 2003 | A1 |
20030125646 | Whitlock | Jul 2003 | A1 |
20030125649 | Mcintosh et al. | Jul 2003 | A1 |
20030133812 | Puff et al. | Jul 2003 | A1 |
20030143189 | Askill et al. | Jul 2003 | A1 |
20030144619 | Augustine | Jul 2003 | A1 |
20030153860 | Nielsen et al. | Aug 2003 | A1 |
20030161735 | Kim et al. | Aug 2003 | A1 |
20030171675 | Rosenberg | Sep 2003 | A1 |
20030175125 | Kwon et al. | Sep 2003 | A1 |
20030175135 | Heo et al. | Sep 2003 | A1 |
20030175798 | Raees et al. | Sep 2003 | A1 |
20030183653 | Bills | Oct 2003 | A1 |
20030188754 | Heaton et al. | Oct 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20030212431 | Brady et al. | Nov 2003 | A1 |
20030219469 | Johnson et al. | Nov 2003 | A1 |
20030225347 | Argenta et al. | Dec 2003 | A1 |
20030230191 | Ohrle et al. | Dec 2003 | A1 |
20040005222 | Yoshida et al. | Jan 2004 | A1 |
20040006319 | Lina et al. | Jan 2004 | A1 |
20040019342 | Nagasuna et al. | Jan 2004 | A1 |
20040024351 | Greter et al. | Feb 2004 | A1 |
20040030304 | Hunt et al. | Feb 2004 | A1 |
20040033466 | Shellard et al. | Feb 2004 | A1 |
20040037897 | Benjamin et al. | Feb 2004 | A1 |
20040039391 | Argenta et al. | Feb 2004 | A1 |
20040049187 | Burnett et al. | Mar 2004 | A1 |
20040054338 | Bybordi et al. | Mar 2004 | A1 |
20040057855 | Gerlach et al. | Mar 2004 | A1 |
20040064111 | Lockwood et al. | Apr 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040066097 | Kobayashi et al. | Apr 2004 | A1 |
20040071568 | Hyeon | Apr 2004 | A1 |
20040071572 | Greter et al. | Apr 2004 | A1 |
20040073152 | Karason et al. | Apr 2004 | A1 |
20040076662 | Riesinger | Apr 2004 | A1 |
20040087884 | Haddock et al. | May 2004 | A1 |
20040115076 | Lilie et al. | Jun 2004 | A1 |
20040118460 | Stinson | Jun 2004 | A1 |
20040122434 | Argenta et al. | Jun 2004 | A1 |
20040126250 | Tsuchiya et al. | Jul 2004 | A1 |
20040127862 | Bubb et al. | Jul 2004 | A1 |
20040127863 | Bubb et al. | Jul 2004 | A1 |
20040156730 | Lilie et al. | Aug 2004 | A1 |
20040163713 | Schulze et al. | Aug 2004 | A1 |
20040167482 | Watson | Aug 2004 | A1 |
20040167617 | Voellmicke et al. | Aug 2004 | A1 |
20040171976 | Johson | Sep 2004 | A1 |
20040171998 | Marasco, Jr. | Sep 2004 | A1 |
20040182237 | Headley et al. | Sep 2004 | A1 |
20040189103 | Duncan et al. | Sep 2004 | A1 |
20040241214 | Kirkwood et al. | Dec 2004 | A1 |
20040249353 | Risk, Jr. et al. | Dec 2004 | A1 |
20050012616 | Forster et al. | Jan 2005 | A1 |
20050020955 | Sanders et al. | Jan 2005 | A1 |
20050031470 | Lee | Feb 2005 | A1 |
20050045461 | Sweetland et al. | Mar 2005 | A1 |
20050065471 | Kuntz | Mar 2005 | A1 |
20050085768 | Greter et al. | Apr 2005 | A1 |
20050090787 | Risk et al. | Apr 2005 | A1 |
20050098031 | Yoon et al. | May 2005 | A1 |
20050110190 | Giardini | May 2005 | A1 |
20050111987 | Yoo et al. | May 2005 | A1 |
20050119737 | Bene et al. | Jun 2005 | A1 |
20050123422 | Lilie | Jun 2005 | A1 |
20050124966 | Karpowicz et al. | Jun 2005 | A1 |
20050129540 | Puff | Jun 2005 | A1 |
20050131327 | Lockwood et al. | Jun 2005 | A1 |
20050135946 | Kang et al. | Jun 2005 | A1 |
20050137539 | Biggie et al. | Jun 2005 | A1 |
20050142007 | Lee et al. | Jun 2005 | A1 |
20050142008 | Jung et al. | Jun 2005 | A1 |
20050155657 | Kack et al. | Jul 2005 | A1 |
20050163635 | Berwanger et al. | Jul 2005 | A1 |
20050165350 | Greter et al. | Jul 2005 | A1 |
20050177086 | Murata et al. | Aug 2005 | A1 |
20050209560 | Boukhny et al. | Sep 2005 | A1 |
20050228329 | Boehringer et al. | Oct 2005 | A1 |
20050230422 | Muller et al. | Oct 2005 | A1 |
20050245850 | Freyre et al. | Nov 2005 | A1 |
20050251117 | Anderson et al. | Nov 2005 | A1 |
20050271526 | Chang et al. | Dec 2005 | A1 |
20050272142 | Horita | Dec 2005 | A1 |
20050276706 | Radue | Dec 2005 | A1 |
20050283105 | Heaton et al. | Dec 2005 | A1 |
20060009744 | Edrman et al. | Jan 2006 | A1 |
20060017332 | Kang et al. | Jan 2006 | A1 |
20060018771 | Song et al. | Jan 2006 | A1 |
20060019144 | Hidaka et al. | Jan 2006 | A1 |
20060024181 | Kim | Feb 2006 | A1 |
20060029650 | Coffey | Feb 2006 | A1 |
20060029675 | Ginther | Feb 2006 | A1 |
20060039806 | Becker | Feb 2006 | A1 |
20060056979 | Yoo et al. | Mar 2006 | A1 |
20060056980 | Yoo et al. | Mar 2006 | A1 |
20060057000 | Hyeon | Mar 2006 | A1 |
20060061024 | Jung et al. | Mar 2006 | A1 |
20060069365 | Sperl et al. | Mar 2006 | A1 |
20060070458 | Jones et al. | Apr 2006 | A1 |
20060073036 | Debrito et al. | Apr 2006 | A1 |
20060079599 | Arthur | Apr 2006 | A1 |
20060079852 | Bubb et al. | Apr 2006 | A1 |
20060086598 | Sneek et al. | Apr 2006 | A1 |
20060107642 | Smith et al. | May 2006 | A1 |
20060110259 | Puff et al. | May 2006 | A1 |
20060118190 | Takehana et al. | Jun 2006 | A1 |
20060122558 | Sherman et al. | Jun 2006 | A1 |
20060149170 | Boynton et al. | Jul 2006 | A1 |
20060173514 | Biel et al. | Aug 2006 | A1 |
20060191575 | Naesje | Aug 2006 | A1 |
20060192259 | Silverbrook | Aug 2006 | A1 |
20060210411 | Hyeon | Sep 2006 | A1 |
20060213527 | Argenta et al. | Sep 2006 | A1 |
20060216165 | Lee | Sep 2006 | A1 |
20060222532 | Lee et al. | Oct 2006 | A1 |
20060228224 | Hong et al. | Oct 2006 | A1 |
20060245947 | Seto et al. | Nov 2006 | A1 |
20060251523 | Lee et al. | Nov 2006 | A1 |
20060253082 | Mcintosh et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060273109 | Keller | Dec 2006 | A1 |
20060282028 | Howard et al. | Dec 2006 | A1 |
20060282174 | Haines | Dec 2006 | A1 |
20060287632 | Sarangapani | Dec 2006 | A1 |
20070004896 | Ito et al. | Jan 2007 | A1 |
20070005028 | Risk et al. | Jan 2007 | A1 |
20070009580 | DiCosmo et al. | Jan 2007 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070032741 | Hibner et al. | Feb 2007 | A1 |
20070032762 | Vogel | Feb 2007 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070038172 | Zamierowski | Feb 2007 | A1 |
20070040454 | Freudenberger et al. | Feb 2007 | A1 |
20070041856 | Hansen et al. | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070078366 | Haggstrom et al. | Apr 2007 | A1 |
20070078444 | Larsson | Apr 2007 | A1 |
20070091614 | Kaisser et al. | Apr 2007 | A1 |
20070128055 | Lee | Jun 2007 | A1 |
20070141101 | Nugent et al. | Jun 2007 | A1 |
20070147947 | Stenton et al. | Jun 2007 | A1 |
20070164047 | Reidt et al. | Jul 2007 | A1 |
20070167927 | Hunt et al. | Jul 2007 | A1 |
20070179460 | Adahan | Aug 2007 | A1 |
20070185463 | Mulligan | Aug 2007 | A1 |
20070196214 | Bocchiola | Aug 2007 | A1 |
20070203062 | Ellis-Behnke et al. | Aug 2007 | A1 |
20070218101 | Johnson et al. | Sep 2007 | A1 |
20070219513 | Lina et al. | Sep 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070255187 | Branch | Nov 2007 | A1 |
20070256428 | Unger et al. | Nov 2007 | A1 |
20070260207 | Ugander et al. | Nov 2007 | A1 |
20070260226 | Jaeb et al. | Nov 2007 | A1 |
20070265586 | Joshi et al. | Nov 2007 | A1 |
20070276195 | Xu et al. | Nov 2007 | A1 |
20070276309 | Xu et al. | Nov 2007 | A1 |
20070282283 | Kaern et al. | Dec 2007 | A1 |
20070295201 | Dadd | Dec 2007 | A1 |
20080004549 | Anderson et al. | Jan 2008 | A1 |
20080009812 | Riesinger | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080020178 | Oehrle et al. | Jan 2008 | A1 |
20080021356 | Castello Escude et al. | Jan 2008 | A1 |
20080031748 | Ihle et al. | Feb 2008 | A1 |
20080033352 | Annis et al. | Feb 2008 | A1 |
20080039761 | Heaton et al. | Feb 2008 | A1 |
20080045887 | Larsson et al. | Feb 2008 | A1 |
20080051708 | Kumar et al. | Feb 2008 | A1 |
20080051716 | Stutz | Feb 2008 | A1 |
20080060550 | MacDonald et al. | Mar 2008 | A1 |
20080071216 | Locke et al. | Mar 2008 | A1 |
20080071234 | Kelch et al. | Mar 2008 | A1 |
20080071235 | Locke et al. | Mar 2008 | A1 |
20080082040 | Kubler et al. | Apr 2008 | A1 |
20080082059 | Fink et al. | Apr 2008 | A1 |
20080089173 | Lu et al. | Apr 2008 | A1 |
20080094753 | Brodkin et al. | Apr 2008 | A1 |
20080108977 | Heaton et al. | May 2008 | A1 |
20080110336 | Bovill et al. | May 2008 | A1 |
20080125697 | Gao | May 2008 | A1 |
20080125698 | Gerg et al. | May 2008 | A1 |
20080132821 | Propp et al. | Jun 2008 | A1 |
20080167593 | Fleischmann | Jul 2008 | A1 |
20080177253 | Boehringer et al. | Jul 2008 | A1 |
20080200905 | Heaton | Aug 2008 | A1 |
20080206155 | Tamarkin et al. | Aug 2008 | A1 |
20080208147 | Argenta et al. | Aug 2008 | A1 |
20080208163 | Wilkie | Aug 2008 | A1 |
20080211435 | Imagawa | Sep 2008 | A1 |
20080223378 | Henderson et al. | Sep 2008 | A1 |
20080234641 | Locke et al. | Sep 2008 | A1 |
20080240942 | Heinrich et al. | Oct 2008 | A1 |
20080243044 | Hunt et al. | Oct 2008 | A1 |
20080254103 | Harris et al. | Oct 2008 | A1 |
20080260551 | Simmons | Oct 2008 | A1 |
20080281281 | Meyer et al. | Nov 2008 | A1 |
20080287880 | Keller | Nov 2008 | A1 |
20080294147 | Radl et al. | Nov 2008 | A1 |
20080300555 | Olson et al. | Dec 2008 | A1 |
20080306407 | Taylor | Dec 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20080310980 | Ramsdorf et al. | Dec 2008 | A1 |
20080312572 | Riesinger | Dec 2008 | A1 |
20080312613 | Heaton et al. | Dec 2008 | A1 |
20080314929 | Keller | Dec 2008 | A1 |
20090005746 | Nielsen et al. | Jan 2009 | A1 |
20090012484 | Nielsen et al. | Jan 2009 | A1 |
20090020561 | Keller | Jan 2009 | A1 |
20090022779 | Kelly et al. | Jan 2009 | A1 |
20090028733 | Duwel | Jan 2009 | A1 |
20090030086 | Eady et al. | Jan 2009 | A1 |
20090036873 | Nielsen et al. | Feb 2009 | A1 |
20090048556 | Durand | Feb 2009 | A1 |
20090053081 | Griffiths | Feb 2009 | A1 |
20090054855 | Blott et al. | Feb 2009 | A1 |
20090071551 | Chalich | Mar 2009 | A1 |
20090081049 | Tian et al. | Mar 2009 | A1 |
20090082740 | Lockwood et al. | Mar 2009 | A1 |
20090087323 | Blakey et al. | Apr 2009 | A1 |
20090093550 | Rolfes et al. | Apr 2009 | A1 |
20090093779 | Riesinger | Apr 2009 | A1 |
20090098073 | MacDonald et al. | Apr 2009 | A1 |
20090114293 | Kanai et al. | May 2009 | A1 |
20090124988 | Coulthard | May 2009 | A1 |
20090125004 | Shen et al. | May 2009 | A1 |
20090129986 | Wimberger-Friedl et al. | May 2009 | A1 |
20090131892 | Karpowicz et al. | May 2009 | A1 |
20090134186 | Keller | May 2009 | A1 |
20090137973 | Karpowicz et al. | May 2009 | A1 |
20090149821 | Scherson et al. | Jun 2009 | A1 |
20090157017 | Ambrosio | Jun 2009 | A1 |
20090157024 | Song | Jun 2009 | A1 |
20090166411 | Kramer et al. | Jul 2009 | A1 |
20090192467 | Hansen et al. | Jul 2009 | A1 |
20090196844 | Choi et al. | Aug 2009 | A1 |
20090198201 | Adahan | Aug 2009 | A1 |
20090204085 | Biggie et al. | Aug 2009 | A1 |
20090206778 | Roh et al. | Aug 2009 | A1 |
20090216170 | Robinson et al. | Aug 2009 | A1 |
20090216204 | Bhavaraju et al. | Aug 2009 | A1 |
20090221977 | Blott et al. | Sep 2009 | A1 |
20090227968 | Vess | Sep 2009 | A1 |
20090227969 | Jaeb | Sep 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090234309 | Vitaris et al. | Sep 2009 | A1 |
20090240185 | Jaeb et al. | Sep 2009 | A1 |
20090254053 | Svensby et al. | Oct 2009 | A1 |
20090254066 | Heaton | Oct 2009 | A1 |
20090259203 | Hu et al. | Oct 2009 | A1 |
20090264807 | Haggstrom et al. | Oct 2009 | A1 |
20090264837 | Adahan | Oct 2009 | A1 |
20090270820 | Johnson | Oct 2009 | A1 |
20090275872 | Addison et al. | Nov 2009 | A1 |
20090275922 | Coulthard et al. | Nov 2009 | A1 |
20090287129 | Boehringer et al. | Nov 2009 | A1 |
20090293887 | Wilkes et al. | Dec 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299255 | Kazala, Jr. et al. | Dec 2009 | A1 |
20090299306 | Buan | Dec 2009 | A1 |
20090304534 | Richter | Dec 2009 | A1 |
20090306580 | Blott et al. | Dec 2009 | A1 |
20090312723 | Blott et al. | Dec 2009 | A1 |
20100004611 | Aali | Jan 2010 | A1 |
20100016767 | Jones et al. | Jan 2010 | A1 |
20100022972 | Lina et al. | Jan 2010 | A1 |
20100022990 | Karpowicz et al. | Jan 2010 | A1 |
20100030170 | Keller et al. | Feb 2010 | A1 |
20100030171 | Canada et al. | Feb 2010 | A1 |
20100030178 | MacMeccan et al. | Feb 2010 | A1 |
20100036305 | Green | Feb 2010 | A1 |
20100036334 | Heagle et al. | Feb 2010 | A1 |
20100042059 | Pratt et al. | Feb 2010 | A1 |
20100063483 | Adahan | Mar 2010 | A1 |
20100068820 | Meathrel et al. | Mar 2010 | A1 |
20100069829 | Hutchinson et al. | Mar 2010 | A1 |
20100069850 | Fabo | Mar 2010 | A1 |
20100069858 | Olson | Mar 2010 | A1 |
20100069863 | Olson | Mar 2010 | A1 |
20100087767 | McNeil | Apr 2010 | A1 |
20100094234 | Ramella et al. | Apr 2010 | A1 |
20100098566 | Kang | Apr 2010 | A1 |
20100100063 | Joshi et al. | Apr 2010 | A1 |
20100100160 | Edman et al. | Apr 2010 | A1 |
20100106112 | Vogel | Apr 2010 | A1 |
20100106117 | Lockwood et al. | Apr 2010 | A1 |
20100121286 | Locke et al. | May 2010 | A1 |
20100122417 | Vrzalik et al. | May 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100145289 | Line et al. | Jun 2010 | A1 |
20100150991 | Bernstein | Jun 2010 | A1 |
20100159192 | Cotton | Jun 2010 | A1 |
20100160878 | Hunt et al. | Jun 2010 | A1 |
20100160880 | Weston | Jun 2010 | A1 |
20100174251 | Weston | Jul 2010 | A1 |
20100191178 | Ross et al. | Jul 2010 | A1 |
20100191196 | Heagle | Jul 2010 | A1 |
20100191198 | Heagle | Jul 2010 | A1 |
20100204663 | Wudyka | Aug 2010 | A1 |
20100207768 | Pidgeon et al. | Aug 2010 | A1 |
20100210986 | Sanders | Aug 2010 | A1 |
20100211030 | Turner et al. | Aug 2010 | A1 |
20100228205 | Hu et al. | Sep 2010 | A1 |
20100230467 | Crisuolo et al. | Sep 2010 | A1 |
20100244780 | Turner | Sep 2010 | A1 |
20100249733 | Blott et al. | Sep 2010 | A9 |
20100262090 | Riesinger | Oct 2010 | A1 |
20100262091 | Larsson | Oct 2010 | A1 |
20100265649 | Singh et al. | Oct 2010 | A1 |
20100268176 | Johnson et al. | Oct 2010 | A1 |
20100268179 | Kelch et al. | Oct 2010 | A1 |
20100268198 | Buan et al. | Oct 2010 | A1 |
20100280435 | Raney et al. | Nov 2010 | A1 |
20100280468 | Haggstrom et al. | Nov 2010 | A1 |
20100280469 | Hall | Nov 2010 | A1 |
20100292632 | Mulvihill et al. | Nov 2010 | A1 |
20100305490 | Coulthard et al. | Dec 2010 | A1 |
20100305526 | Robinson et al. | Dec 2010 | A1 |
20100318043 | Malhi et al. | Dec 2010 | A1 |
20100318052 | Ha et al. | Dec 2010 | A1 |
20100318071 | Wudyka | Dec 2010 | A1 |
20100324510 | Andresen et al. | Dec 2010 | A1 |
20100331797 | Patel et al. | Dec 2010 | A1 |
20110000069 | Ramsdorf et al. | Jan 2011 | A1 |
20110004172 | Eckstein et al. | Jan 2011 | A1 |
20110004173 | Hu et al. | Jan 2011 | A1 |
20110015587 | Tumey et al. | Jan 2011 | A1 |
20110015593 | Svedman et al. | Jan 2011 | A1 |
20110020588 | Kinugawa et al. | Jan 2011 | A1 |
20110021431 | Jones et al. | Jan 2011 | A1 |
20110022013 | Boynton et al. | Jan 2011 | A1 |
20110028919 | Johnnison et al. | Feb 2011 | A1 |
20110028920 | Johannison | Feb 2011 | A1 |
20110028921 | Hartwell et al. | Feb 2011 | A1 |
20110033503 | Sinko et al. | Feb 2011 | A1 |
20110034869 | Greter et al. | Feb 2011 | A1 |
20110034888 | Aali | Feb 2011 | A1 |
20110034892 | Buan | Feb 2011 | A1 |
20110034894 | Riesinger | Feb 2011 | A1 |
20110038741 | Lissner et al. | Feb 2011 | A1 |
20110054422 | Locke et al. | Mar 2011 | A1 |
20110054423 | Blott et al. | Mar 2011 | A1 |
20110071415 | Karwoski et al. | Mar 2011 | A1 |
20110081267 | McCrone et al. | Apr 2011 | A1 |
20110086077 | McCrea et al. | Apr 2011 | A1 |
20110092927 | Wilkes et al. | Apr 2011 | A1 |
20110092958 | Jacobs | Apr 2011 | A1 |
20110098600 | Matsumura et al. | Apr 2011 | A1 |
20110103984 | Santa | May 2011 | A1 |
20110105963 | Hu et al. | May 2011 | A1 |
20110106030 | Scholz | May 2011 | A1 |
20110112492 | Bharti et al. | May 2011 | A1 |
20110118683 | Weston | May 2011 | A1 |
20110125066 | Robinson et al. | May 2011 | A1 |
20110130712 | Topaz | Jun 2011 | A1 |
20110171044 | Flanigan | Jul 2011 | A1 |
20110172617 | Riesinger | Jul 2011 | A1 |
20110176945 | Drevet | Jul 2011 | A1 |
20110176946 | Drevet | Jul 2011 | A1 |
20110224631 | Simmons | Sep 2011 | A1 |
20110229352 | Herbert | Sep 2011 | A1 |
20110230849 | Coulthard et al. | Sep 2011 | A1 |
20110236265 | Hasui et al. | Sep 2011 | A1 |
20110236277 | Lee et al. | Sep 2011 | A1 |
20110251569 | Turner et al. | Oct 2011 | A1 |
20110257572 | Locke et al. | Oct 2011 | A1 |
20110270201 | Bubb et al. | Nov 2011 | A1 |
20110270202 | Boehringer et al. | Nov 2011 | A1 |
20110282309 | Adie et al. | Nov 2011 | A1 |
20110295220 | Heaton et al. | Dec 2011 | A1 |
20110311379 | Hale et al. | Dec 2011 | A1 |
20110313373 | Riesinger | Dec 2011 | A1 |
20110313374 | Lockwood et al. | Dec 2011 | A1 |
20120000208 | Hon et al. | Jan 2012 | A1 |
20120008817 | Grinker et al. | Jan 2012 | A1 |
20120041399 | Blott et al. | Feb 2012 | A1 |
20120046625 | Johannison | Feb 2012 | A1 |
20120095380 | Gergley et al. | Apr 2012 | A1 |
20120109085 | McNeil | May 2012 | A1 |
20120130332 | Cotton et al. | May 2012 | A1 |
20120136325 | Allen et al. | May 2012 | A1 |
20120157942 | Weston | Jun 2012 | A1 |
20120184930 | Johannison | Jul 2012 | A1 |
20120220960 | Ruland | Aug 2012 | A1 |
20120251359 | Neelakantan et al. | Oct 2012 | A1 |
20120259299 | Ryu et al. | Oct 2012 | A1 |
20120271256 | Locke et al. | Oct 2012 | A1 |
20120289895 | Tsoukalis | Nov 2012 | A1 |
20120289913 | Eckstein et al. | Nov 2012 | A1 |
20120289914 | Eckstein et al. | Nov 2012 | A1 |
20120301341 | Ota et al. | Nov 2012 | A1 |
20130017110 | Villagomez et al. | Jan 2013 | A1 |
20130042753 | Becker et al. | Feb 2013 | A1 |
20130085462 | Nip et al. | Apr 2013 | A1 |
20130090613 | Kelch et al. | Apr 2013 | A1 |
20130090615 | Jaeb et al. | Apr 2013 | A1 |
20130102979 | Coulthard et al. | Apr 2013 | A1 |
20130110058 | Adie et al. | May 2013 | A1 |
20130116635 | Fleischmann | May 2013 | A1 |
20130118622 | Patzold et al. | May 2013 | A1 |
20130123755 | Locke et al. | May 2013 | A1 |
20130138054 | Fleischmann | May 2013 | A1 |
20130144230 | Wu et al. | Jun 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130165878 | Heagle | Jun 2013 | A1 |
20130209277 | Locke et al. | Aug 2013 | A1 |
20130209279 | Locke et al. | Aug 2013 | A1 |
20130209281 | Locke et al. | Aug 2013 | A1 |
20130213506 | Chen et al. | Aug 2013 | A1 |
20130223979 | Locke et al. | Aug 2013 | A1 |
20130267917 | Pan et al. | Oct 2013 | A1 |
20130274688 | Weston | Oct 2013 | A1 |
20130280113 | Miranda et al. | Oct 2013 | A1 |
20130296762 | Toth | Nov 2013 | A1 |
20130331822 | Patel et al. | Dec 2013 | A1 |
20130338614 | Heaton et al. | Dec 2013 | A1 |
20130340870 | Ito et al. | Dec 2013 | A1 |
20140018753 | Joshi et al. | Jan 2014 | A1 |
20140072149 | Yan et al. | Mar 2014 | A1 |
20140100516 | Hunt et al. | Apr 2014 | A1 |
20140114236 | Gordon | Apr 2014 | A1 |
20140114237 | Gordon | Apr 2014 | A1 |
20140114268 | Auguste et al. | Apr 2014 | A1 |
20140155849 | Heaton et al. | Jun 2014 | A1 |
20140163490 | Locke et al. | Jun 2014 | A1 |
20140194835 | Ehlert | Jul 2014 | A1 |
20140228791 | Hartwell | Aug 2014 | A1 |
20140236106 | Locke et al. | Aug 2014 | A1 |
20140236109 | Greener | Aug 2014 | A1 |
20140249493 | Hartwell | Sep 2014 | A1 |
20140276487 | Locke et al. | Sep 2014 | A1 |
20140303551 | Germain et al. | Oct 2014 | A1 |
20140316359 | Collinson et al. | Oct 2014 | A1 |
20140323906 | Peatfield et al. | Oct 2014 | A1 |
20140343519 | Weston | Nov 2014 | A1 |
20150025482 | Begin et al. | Jan 2015 | A1 |
20150032035 | Banwell et al. | Jan 2015 | A1 |
20150051560 | Askem | Feb 2015 | A1 |
20150065965 | Haggstrom et al. | Mar 2015 | A1 |
20150073363 | Kelch et al. | Mar 2015 | A1 |
20150094673 | Pratt et al. | Apr 2015 | A1 |
20150094674 | Pratt et al. | Apr 2015 | A1 |
20150209492 | Blott et al. | Jul 2015 | A1 |
20150258256 | Jaeb et al. | Sep 2015 | A1 |
20150250931 | Bharti et al. | Oct 2015 | A1 |
20160081859 | Hartwell | Mar 2016 | A1 |
20160317357 | Vitaris et al. | Nov 2016 | A1 |
20170128642 | Buan | May 2017 | A1 |
20170181896 | Hartwell | Jun 2017 | A1 |
20170181897 | Hartwell | Jun 2017 | A1 |
20170266051 | Hartwell | Sep 2017 | A1 |
20180133065 | Hartwell | May 2018 | A1 |
20180214317 | Hartwell | Aug 2018 | A1 |
20180235816 | Hartwell | Aug 2018 | A1 |
20180311078 | Hartwell | Nov 2018 | A1 |
20190142647 | Hartwell | May 2019 | A1 |
20190224387 | Weston | Jul 2019 | A1 |
20200061254 | Joshi et al. | Feb 2020 | A1 |
Number | Date | Country |
---|---|---|
2186074 | Dec 1994 | CN |
201664463 | Dec 2010 | CN |
847475 | Aug 1952 | DE |
3 137 839 | Mar 1983 | DE |
3 032 092 | Oct 1984 | DE |
34 43 101 | May 1986 | DE |
3 935 818 | May 1991 | DE |
4 012 232 | Oct 1991 | DE |
198 44 355 | Apr 2000 | DE |
20 2004 017 052 | Jul 2005 | DE |
0 020 662 | Jul 1984 | EP |
0 208 395 | Jan 1987 | EP |
0 340 018 | Nov 1989 | EP |
0 355 186 | Feb 1990 | EP |
0353972 | Feb 1990 | EP |
0 512 543 | Nov 1992 | EP |
0 521 434 | Jan 1993 | EP |
0 619 105 | Oct 1994 | EP |
0 759 521 | Feb 1997 | EP |
0 775 825 | May 1997 | EP |
0 793 019 | Sep 1997 | EP |
0 809 028 | Nov 1997 | EP |
0 858 810 | Aug 1998 | EP |
0 777 504 | Oct 1998 | EP |
0 888 141 | Jan 1999 | EP |
0 898 076 | Feb 1999 | EP |
1 007 015 | Jun 2000 | EP |
1 013 290 | Jun 2000 | EP |
1 029 585 | Aug 2000 | EP |
1 105 171 | Jun 2001 | EP |
1 105 180 | Jun 2001 | EP |
1 107 813 | Jun 2001 | EP |
1 411 874 | Jul 2001 | EP |
1 030 657 | Oct 2001 | EP |
1 306 123 | May 2003 | EP |
1 440 737 | Jul 2004 | EP |
1 449 971 | Aug 2004 | EP |
1 263 366 | Jul 2006 | EP |
1 726 276 | Nov 2006 | EP |
1 923 077 | Nov 2006 | EP |
1 880 840 | Jan 2008 | EP |
1 476 217 | Mar 2008 | EP |
1 955 887 | Aug 2008 | EP |
1 985 270 | Oct 2008 | EP |
1 121 163 | Nov 2008 | EP |
2 185 206 | Jan 2009 | EP |
2 178 573 | Feb 2009 | EP |
2 098 257 | Sep 2009 | EP |
2 111 804 | Oct 2009 | EP |
2 161 448 | Mar 2010 | EP |
2 326 295 | Mar 2010 | EP |
2 216 573 | Aug 2010 | EP |
2 218 431 | Aug 2010 | EP |
2 302 127 | Mar 2011 | EP |
2 335 749 | Jun 2011 | EP |
2 349 155 | Aug 2011 | EP |
2 420 214 | Feb 2012 | EP |
2 021 046 | Mar 2012 | EP |
2 462 908 | Jun 2012 | EP |
2 603 699 | Jun 2013 | EP |
2 305 325 | Apr 2014 | EP |
2 345 437 | Apr 2014 | EP |
2 687 245 | Sep 2014 | EP |
2 544 642 | Jan 2015 | EP |
3 072 542 | Sep 2016 | EP |
3 062 751 | Aug 2017 | EP |
3 257 486 | Dec 2017 | EP |
1 163 907 | Oct 1958 | FR |
2 939 320 | Jun 2010 | FR |
114754 | Apr 1918 | GB |
236350 | Jul 1925 | GB |
641061 | Aug 1950 | GB |
1224009 | Mar 1971 | GB |
1255395 | Dec 1971 | GB |
1400124 | Jul 1975 | GB |
1549756 | Aug 1979 | GB |
2061732 | May 1981 | GB |
2195255 | Apr 1988 | GB |
2273133 | Jun 1994 | GB |
2288734 | Nov 1995 | GB |
2306580 | May 1997 | GB |
2307180 | May 1997 | GB |
2378392 | Feb 2003 | GB |
2415908 | Jan 2006 | GB |
2424582 | Oct 2006 | GB |
2435419 | Feb 2007 | GB |
2433298 | Mar 2007 | GB |
2511523 | Sep 2014 | GB |
0722820 | Jul 2019 | GB |
59-86824 | Jun 1984 | JP |
59-87824 | Jun 1984 | JP |
S5986824 | Jun 1984 | JP |
S61-80018 | May 1986 | JP |
S6180018 | May 1986 | JP |
H04-354722 | Dec 1992 | JP |
2001-314479 | Nov 2001 | JP |
2003-165843 | Jun 2003 | JP |
2004-000465 | Jan 2004 | JP |
2005-334188 | Dec 2005 | JP |
131622 | Aug 2013 | RU |
1251912 | Apr 1983 | SU |
WO 198300742 | Mar 1983 | WO |
WO 198401904 | May 1984 | WO |
WO 199011795 | Oct 1990 | WO |
WO 199100718 | Jan 1991 | WO |
WO 1992009301 | Jun 1992 | WO |
WO 199209651 | Jun 1992 | WO |
WO 199220299 | Nov 1992 | WO |
WO 199306802 | Apr 1993 | WO |
WO 199309176 | May 1993 | WO |
WO 1994020133 | Sep 1994 | WO |
WO 199421312 | Sep 1994 | WO |
WO 199605873 | Feb 1996 | WO |
WO 199640174 | Dec 1996 | WO |
WO 199703717 | Feb 1997 | WO |
WO 199733922 | Sep 1997 | WO |
WO 199742986 | Nov 1997 | WO |
WO 199803267 | Jan 1998 | WO |
WO 199806444 | Feb 1998 | WO |
WO 199901173 | Jan 1999 | WO |
WO 199917698 | Apr 1999 | WO |
WO 199930629 | Jun 1999 | WO |
WO 1999047097 | Sep 1999 | WO |
WO 199965536 | Dec 1999 | WO |
WO 2000000743 | Jan 2000 | WO |
WO 2000007653 | Feb 2000 | WO |
WO 200038752 | Jul 2000 | WO |
WO 200049968 | Aug 2000 | WO |
WO 200050143 | Aug 2000 | WO |
WO 200056378 | Sep 2000 | WO |
WO 200059424 | Oct 2000 | WO |
WO 200061206 | Oct 2000 | WO |
WO 200062827 | Oct 2000 | WO |
WO 2000064396 | Nov 2000 | WO |
WO 2000079154 | Dec 2000 | WO |
WO 200119430 | Mar 2001 | WO |
WO 200134223 | May 2001 | WO |
WO 200137922 | May 2001 | WO |
WO 200137922 | May 2001 | WO |
WO 2001062312 | Aug 2001 | WO |
WO 2001066017 | Sep 2001 | WO |
WO 2001085248 | Nov 2001 | WO |
WO 2001089431 | Nov 2001 | WO |
WO 200202079 | Jan 2002 | WO |
WO 2002070040 | Sep 2002 | WO |
WO 2002083046 | Oct 2002 | WO |
WO 2002092783 | Nov 2002 | WO |
WO 2002094256 | Nov 2002 | WO |
WO 2002102864 | Dec 2002 | WO |
WO 2003074100 | Sep 2003 | WO |
WO 2003085810 | Oct 2003 | WO |
WO 2003092620 | Nov 2003 | WO |
WO 2004007960 | Jan 2004 | WO |
WO 2004024300 | Mar 2004 | WO |
WO 2004037334 | May 2004 | WO |
WO 2004041064 | May 2004 | WO |
WO 2004054632 | Jul 2004 | WO |
WO 2004077387 | Sep 2004 | WO |
WO 2004081421 | Sep 2004 | WO |
WO 2005009488 | Feb 2005 | WO |
WO 2005016179 | Feb 2005 | WO |
WO 2005017000 | Feb 2005 | WO |
WO 2005018695 | Mar 2005 | WO |
WO 2005025447 | Mar 2005 | WO |
WO 2005025666 | Mar 2005 | WO |
WO 2005046761 | May 2005 | WO |
WO 2005046762 | May 2005 | WO |
WO 2005051461 | Jun 2005 | WO |
WO 2005070480 | Aug 2005 | WO |
WO 2005079718 | Sep 2005 | WO |
WO 2005082435 | Sep 2005 | WO |
WO 2005105175 | Nov 2005 | WO |
WO 2005105180 | Nov 2005 | WO |
WO 2005115497 | Dec 2005 | WO |
WO 2005118011 | Dec 2005 | WO |
WO 2005123170 | Dec 2005 | WO |
WO 2006014534 | Feb 2006 | WO |
WO 2006030054 | Mar 2006 | WO |
WO 2006034128 | Mar 2006 | WO |
WO 2006048246 | May 2006 | WO |
WO 2006052745 | May 2006 | WO |
WO 2006052839 | May 2006 | WO |
WO 2006056294 | Jun 2006 | WO |
WO 2006058801 | Jun 2006 | WO |
WO 2006062276 | Jun 2006 | WO |
WO 2006081403 | Aug 2006 | WO |
WO 2006092333 | Sep 2006 | WO |
WO 2006116992 | Nov 2006 | WO |
WO 2006117207 | Nov 2006 | WO |
WO 2006135506 | Dec 2006 | WO |
WO 2007002835 | Jan 2007 | WO |
WO 2007013064 | Feb 2007 | WO |
WO 2007019038 | Feb 2007 | WO |
WO 2007024230 | Mar 2007 | WO |
WO 2007030598 | Mar 2007 | WO |
WO 2007030599 | Mar 2007 | WO |
WO 2007030601 | Mar 2007 | WO |
WO 2007031757 | Mar 2007 | WO |
WO 2007051599 | May 2007 | WO |
WO 2007084792 | Jul 2007 | WO |
WO 2007085396 | Aug 2007 | WO |
WO 2007106592 | Sep 2007 | WO |
WO 2007106594 | Sep 2007 | WO |
WO 2007124198 | Nov 2007 | WO |
WO 2007133618 | Nov 2007 | WO |
WO 2008013896 | Jan 2008 | WO |
WO 2008027449 | Mar 2008 | WO |
WO 2008031418 | Mar 2008 | WO |
WO 2008036345 | Mar 2008 | WO |
WO 2008039223 | Apr 2008 | WO |
WO 2008040020 | Apr 2008 | WO |
WO 2008041926 | Apr 2008 | WO |
WO 2008062176 | May 2008 | WO |
WO 2008076407 | Jun 2008 | WO |
WO 2008082444 | Jul 2008 | WO |
WO 2008100437 | Aug 2008 | WO |
WO 2008100440 | Aug 2008 | WO |
WO 2008112304 | Sep 2008 | WO |
WO 2008134544 | Nov 2008 | WO |
WO 2008134774 | Nov 2008 | WO |
WO 2008141228 | Nov 2008 | WO |
WO 2008141470 | Nov 2008 | WO |
WO 2009019227 | Feb 2009 | WO |
WO 2009019229 | Feb 2009 | WO |
WO 2009034322 | Mar 2009 | WO |
WO 2009146441 | Mar 2009 | WO |
WO 2009042514 | Apr 2009 | WO |
WO 2009047524 | Apr 2009 | WO |
WO 2009052193 | Apr 2009 | WO |
WO 2009060327 | May 2009 | WO |
WO 2009062327 | May 2009 | WO |
WO 2009066105 | May 2009 | WO |
WO 2009066106 | May 2009 | WO |
WO 2009070905 | Jun 2009 | WO |
WO 2009078790 | Jun 2009 | WO |
WO 2009089390 | Jul 2009 | WO |
WO 2009095170 | Aug 2009 | WO |
WO 2009098696 | Aug 2009 | WO |
WO 2009103031 | Aug 2009 | WO |
WO 2009111657 | Sep 2009 | WO |
WO 2009117635 | Sep 2009 | WO |
WO 2009120951 | Oct 2009 | WO |
WO 2009122989 | Oct 2009 | WO |
WO 2009124100 | Oct 2009 | WO |
WO 2009126833 | Oct 2009 | WO |
WO 2009145703 | Dec 2009 | WO |
WO 2009151380 | Dec 2009 | WO |
WO 2009156709 | Dec 2009 | WO |
WO 2009158124 | Dec 2009 | WO |
WO 2009158128 | Dec 2009 | WO |
WO 2009158130 | Dec 2009 | WO |
WO 2010026251 | Mar 2010 | WO |
WO 2010033271 | Mar 2010 | WO |
WO 2010051068 | May 2010 | WO |
WO 2010051418 | May 2010 | WO |
WO 2010059712 | May 2010 | WO |
WO 2010072309 | Jul 2010 | WO |
WO 2010072349 | Jul 2010 | WO |
WO 2010072395 | Jul 2010 | WO |
WO 2010075313 | Jul 2010 | WO |
WO 2010083135 | Jul 2010 | WO |
WO 2010118316 | Oct 2010 | WO |
WO 2010120776 | Oct 2010 | WO |
WO 2010141271 | Dec 2010 | WO |
WO 2010142959 | Dec 2010 | WO |
WO 2010147592 | Dec 2010 | WO |
WO 2011019476 | Feb 2011 | WO |
WO 2011023275 | Mar 2011 | WO |
WO 2011082461 | Jul 2011 | WO |
WO 2011135285 | Nov 2011 | WO |
WO 2011135286 | Nov 2011 | WO |
WO 2011135287 | Nov 2011 | WO |
WO 2011144888 | Nov 2011 | WO |
WO 2011148188 | Dec 2011 | WO |
WO 2012022484 | Feb 2012 | WO |
WO 2012028842 | Mar 2012 | WO |
WO 2012048179 | Apr 2012 | WO |
WO 2012078707 | Jun 2012 | WO |
WO 2012088572 | Jul 2012 | WO |
WO 2012131237 | Oct 2012 | WO |
WO 2012140180 | Oct 2012 | WO |
WO 2012140378 | Oct 2012 | WO |
WO 2012143665 | Oct 2012 | WO |
WO 2013006932 | Jan 2013 | WO |
WO 2013010907 | Jan 2013 | WO |
WO 2013019017 | Feb 2013 | WO |
WO 2013064852 | May 2013 | WO |
WO 2013065423 | May 2013 | WO |
WO 2013083800 | Jun 2013 | WO |
WO 2013090810 | Jun 2013 | WO |
WO 2013117945 | Aug 2013 | WO |
WO 2013118447 | Aug 2013 | WO |
WO 2013119854 | Aug 2013 | WO |
WO 2013133652 | Sep 2013 | WO |
WO 2013136181 | Sep 2013 | WO |
WO 2013149078 | Oct 2013 | WO |
WO 2014008348 | Jan 2014 | WO |
WO 2014016759 | Jan 2014 | WO |
WO 2014020440 | Feb 2014 | WO |
WO 2014020443 | Feb 2014 | WO |
WO 2014108476 | Jul 2014 | WO |
WO 2014113253 | Jul 2014 | WO |
WO 2014113504 | Jul 2014 | WO |
WO 2014107285 | Sep 2014 | WO |
WO 2014143488 | Sep 2014 | WO |
WO 2015022334 | Feb 2015 | WO |
WO 2015022340 | Feb 2015 | WO |
WO 2015023515 | Feb 2015 | WO |
WO 2015031216 | Mar 2015 | WO |
Entry |
---|
US 6,216,701 B1, 04/2001, Heaton et al. (withdrawn) |
US 6,306,115 B1, 10/2001, Kelly et al. (withdrawn) |
Davydov Y.A., et al., “Concepts of Clinico-Biological Management of Wound Process in Treatment of Purulent Wounds with the Help of Vacuum Therapy,” Vestnik Chirurgia, Feb. 1991 Edition, pp. 132-135. |
Preliminary Summary of Facts and Submission, re the Opposition of European Patent No. EP3000448, dated Apr. 20, 2020, 8 pages. |
“Technology Watch”, May 1989, in 1 page. |
Hersle, K. et al., “Uses of Dextranomer Absorbent Pads After Cryosurgery of Cutaneous Malignancies”, The Journal of Dermatologic Surgery and Oncology, vol. 8, Jan. 1982, in 4 pages. |
Consolidated List of Cited Opposition Documents, re European Patent No. EP 3 000 448, dated Jul. 22, 2019, in 1 page. |
Notice of Opposition—Statement of Facts and Evidence, re European Patent No. EP 2 214 611, dated Sep. 26, 2019, in 24 pages. |
Notice of Opposition—Statement of Facts and Evidence, re European Patent No. EP 3 000 448, dated Jul. 16, 2019, in 12 pages. |
Reply of the Patent Proprietor to the Notice(s) of Opposition, re the Opposition of European Patent No. 3 000 448, dated Dec. 6, 2019, in 12 pages. |
Reply of the Patent Proprietor to the Notice of Opposition, re European Patent No. EP 2 214 611, dated Feb. 21, 2020, in 55 pages. |
U.S. Appl. No. 14/446,688 Pub'd 2014/0343519, Jul. 30, 2014, Weston. |
U.S. Appl. No. 61/828,604, filed May 29, 2013, Collinson et al. |
U.S. Appl. No. 61/829,187, filed May 30, 2013, Collinson et al. |
U.S. Appl. No. 61/906,865, filed Nov. 20, 2013, Collinson et al. |
U.S. Appl. No. 61/907,350, filed Nov. 21, 2013, Collinson et al. |
Achterberg, V., Ph.D., Hydroactive dressings and serum proteins: an in vitro study, Journal of Wound Care, February, vol. 5, No. 2, 1996, pp. 79-82. |
Argenta, Louis C., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment; Clinical Experience”, Ann Plas Surg 1997;38:563-577 (Dec. 10, 1996). |
Aubrey, D.A., et al., “Treatment of the Perineal Wound after Proctectomy by Intermittent Irrigation”, Arch. Surg., vol. 119, Oct. 1984, pp. 1141-1144. |
Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues”, in Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvash State University, Cheboksary, USSR 1986) pp. 94-96. |
Bevan, D. et al., “Diverse and potent activities of HGF/SF in skin wound repair”, Journal of Pathology, vol. 203, 2004, pp. 831-838. |
Braglina, I.O., et al. “Russian Chemical Bulletin”, Dec. 31, 1983. |
Chariker, M.E. et al., “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage”, Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
Chintamani, et al., “Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer—a prospective randomized clinical trial”, Research Article (Jan. 27, 2005), 1-5. |
Davydov, Y. A. et al., “The Bacteriological & Cytological Assessment of Vacuum Therapy of Purulent Wounds”, Vestnik Chirurgia, Oct. 1998 Edition 1987, pp. 48-52. |
Davydov, Yu A., et al., “Concepts for Clinical Biological Management of the Wound Process in the Treatment of Purulent Wounds Using Vacuum Therapy”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 15-17. |
Davydov, Yu A., et al., “The Bacteriological and Cytological Assessment of Vacuum Therapy of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 11-14, in 4 pages. |
Davydov, Yu A., et al., “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 5-7. |
De Lange, M.Y. , et al., “Vacuum-Assisted Closure: Indications and Clinical Experience”, Eur J Plast Surg (2000) 2;178-182 (Feb. 9, 2000). |
Dilmaghani et al., “A Method for Closed Irrigation and Suction Therapy in Deep Wound Infections,” Journal of Bone and Joint Surgery, 1969, vol. 51-A, No. 2, pp. 323-342. |
English Translation of Invalidity Suit by KCI Medizinprodukte GmbH versus Kalypto Medical, Inc., concerning declaration of invalidity of the German part of the European Patent No. 2 021 046 (German application No. 60 2007 021 330.4) dated Mar. 11, 2015 in 38 pages. EP 2 021 046 is related to the present application by virtue of a common priority claim to U.S. Appl. No. 11/432,855, now U.S. Pat. No. 7,615,036, and U.S. Appl. No. 11/610,458, now U.S. Pat. No. 7,779,625. |
Greer, et al., Techniques for Applying Subatmospheric Pressure Dressing to Wounds in Difficult Regions of Anatomy, JWOCN, vol. 26, No. 5, 1999 pp. 250-253. |
Hartz, R.S. et al., Healing of the Perineal Wound, Arch. Surg., Apr. 1980, 115, 471-474. |
Health Technology, Literature R., “Vacuum Assisted Closure Therapy for Wound Care”, Health Technology Literature Review, Dec. 2004, pp. 3-59. |
Info V.A.C. User Manual—KCI—Dec. 2006, in 76 pages. |
International Search Report, re PCT Application No. PCT/GB2008/051090, dated Mar. 4, 2009. |
International Preliminary Report on Patentability, re PCT Application No. PCT/GB2008/051090, dated May 25, 2010. |
Kalypto Medical, NPD 1000 Negative Pressure Wound Care System, Clinician & Patient Instructions for Use (publication date unknown, believed to be Feb. 2010). |
Kalypto Medical, NPD 1000 Product Brochure (publication date unknown, believed to be Nov. 2010). |
Kendall ULTEC Hydrocolloid Dressing (4″×4″), product ordering page, web page downloaded Jul. 13, 2014, in 1 page. |
Khirugii, Vestnik, “A Collection of Published Studies Complementing the Research and Innovation of Wound Care”, The Kremlin Papers, Perspectives in Wound Care, Russian Medical Journal, Vestnik Khirurgii, Blue Sky Publishing (2004), 2-17. |
Kostiuchenok, B. M. et al., “The Vacuum Effect in the Surgical Treatment of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California, 2004, pp. 3-4 (English translation only). |
Landis, E.M. and J.H. Gibbon, Jr., The Effects of Alternate Suction and Pressure on Blood Flow to the Lower Extremities, Alternate Suction and Pressure, J Clin Invest. Sep. 1993, 12(5): 925-961. |
Advantec MFS, Inc., “Membrane Filters” (catalog), accessed Jan. 29, 2016 (publication date unknown, but believed to be copyright 2001-2011), in 17 pages. URL: http://www.advantecmfs.com/catalog/filt/membrane.pdf#page=11. |
Mitchell, R. et al., “Role of Stem Cells in Tissue Homeostasis”, Pocket Companion to Robbins and Cotran Pathologic Basis of Disease, 7th Edition, 2006. |
Morykwas, M. J., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997) 553-562. |
Morykwas, M. J., et al.: “Nonsurgical Modalities to Enhance Healing and Care of Soft Tissue Wounds”, Journal of the Southern Orthopaedic Association, vol. 6, No. 4 Winter 1997 in 12 pages. |
Nursing75, Wound Suction: Better Drainage with Fewer Problems, Nursing, vol. 5, No. 10, Oct. 1975, pp. 52-55. |
Prevena™ Incision Management System, Clinician Guide, pp. 1-9, Jan. 2010. |
Prevena™ Incision Management System, Patient Guide, pp. 1-2, Jan. 2010. |
Protz, Kerstin: “Moderne Wundauflagen unterstutzen Heilungsprozess”, Wundversorgung: Indikation und Anwendung, Geriatrie Journal, Apr. 2005, pp. 3333-3339, with translation, in 17 pages. |
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System”, spiral booklet, Mar. 2011, in 7 pages. |
Solovev, V. A., et al., “The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract—Guidelines” USSR Ministry of Health, S. M. Kirov Gorky State Medical Institute, 1987 (with English translation). |
Solovev, V.A. “Treatment and Prevention of Suture Failures after Gastric Resection” (Dissertation Abstract) (S.M. Kirov Gorky State Medical Institute, Gorky USSR 1988). |
Stewart, J., “World Wide Wounds—Next Generation of Products for Wound Management”, 2002, in 13 pages. |
Svedman, P., “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers,” Scand J. Plast. Reconstr. Surg., 19:211-213, 1985. |
Svedman, P., “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 1983, pp. 532-534. |
Svedman, P., “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Med. Science: Biomed. Tech.; Clinic. Med.; Surg. and Transplantation, 1979, 7, p. 221. |
Svedman, P. et al., “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
Swift, et al, “Quorum Sensing in Aeromonas hydrophila and Aeromonas salmonicida: Identification of LuxRI Homologs AhyRI and AsaRI and Their Cognate N-Acylhomoserine Lactone Signal Molecules,” J. Bacteriol., 179(17):5271-5281 (1997). |
Teder, H. et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, vol. 3, 1990, pp. 399-407. |
Tribble, D. E., “An Improved Sump Drain-Irrigation Device of Simple Construction”, Archives of Surgery New York, vol. 105, Sep. 1972, in 4 pages. |
Usupov, Y. N., et al., “Active Wound Drainage”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), pp. 8-10. |
Venturi, Mark L., “Mechanisms and Clinical Applications of the Vacuum-Assisted Closure (VAC) Device”, Am J Clin Dermatol (2005) 693, 185-194; Review Article (2005),185-194. |
Vijanto, J. and J. Raekallio, Local Hyperalimentation of Open Wounds, Br. J. surg., 1976, 63, 427-430. |
Webb, New Techniques in Wound Management: Vacuum-Assisted Wound Closure, Journal of the American Academy of Orthopadic Surgeons, vol. 10, No. 5, Sep. 2002, pp. 303-311. |
Westaby, S., et al., “A Wound Irrigation Device”, The Lancet, Sep. 2, 1978, pp. 503-504. |
Wooding-Scott, Margaret, et al., “No Wound is Too Big for Resourceful Nurses,” RN Dec. 1988, pp. 22-25 USA. |
Wound Suction, Nursing, Oct. 1975, USA pp. 52-53. |
Annex to the Communication, re the Opposition of European Patent No. EP2214610, dated Mar. 3, 2020, 17 pages. |
BASF, Elastollan Physical Properties, 2020, 1 page. |
Communication of a Notice of Opposition and Opponent's Statement of Facts and Arguments for European Patent No. EP3254650, dated Sep. 30, 2020, 23 pages. |
Declaration of Chris Locke submitted in the Opposition against European Patent No. EP2563308, dated Sep. 7, 2016, 6 pages. |
KCI, “V.A.C. Freedom User's Guide,” May 2002, 16 pages. |
Kennedy J.F., et al., “Advanced Textiles for Wound Care” (Second Edition), Chapter 10, 2019, 23 pages. |
Notice of Opposition—Statement of Facts and Evidence of the European Patent No. 2214610, dated Jul. 8, 2019, 18 pages. |
Notice of Response in Summons to Attend Oral Proceedings pursuant to rule 115(1) EPC for European Patent No. 2214611, mailed on Jun. 23, 2020, 19 pages. |
Notice of Response in Summons to Attend Oral Proceedings pursuant to rule 115(1) EPC for European Patent No. 3000448, mailed on Jun. 23, 2020, 6 pages. |
Opponent's Written Submission in Preparation for the Oral Proceedings, for the Opposition of European U.S. Pat. No. 2214610, dated Sep. 25, 2020, 5 pages. |
Proprietor's Written Submission in Preparation for the Oral Proceedings, for the Opposition of European Patent No. 2214610, dated Oct. 1, 2020, 20 pages. |
Reply of the Patent Proprietor to the Notice of Opposition, re the Opposition of European Patent No. 2214610, dated Dec. 3, 2019, 25 pages. |
Summons to Attend Oral Proceedings pursuant to rule 115(1) EPC and Preliminary Summary and Preliminary Opinion for Patent No. 3000448, mailed on Oct. 22, 2020, 9 pages. |
Written Submissions in Preparation to Oral Proceedings, the Opposition of European Patent No. 3000448, dated Sep. 24, 2020, 10 pages. |
Brief Communication—Letter from the Opponent, re the Opposition of European Pat. No. 3000448, dated Apr. 21, 2021, 3 pages. |
Brief Communication—Letter from the Proprietor of the Patent, re the Opposition for Simmons & Simmons for European Pat. No. 3000448, dated Apr. 23, 2021, 12 pages. |
Brief Communication—Letter from the Proprietor of the Patent, re the Opposition for Simmons & Simmons for European Pat. No. 3254650, dated Mar. 5, 2021, 10 pages. |
Interlocutory decision in Opposition proceedings (Art. 101(3)(a) and 106(2) EPC) for European Pat. No. 2214611, dated May 20, 2021, 87 pages. |
Information about the Result of Oral Proceedings for European Pat. No. 3000448, dated Jun. 14, 2021, 7 pages. |
Minutes of the Oral Proceedings, opposition procedure and Summary of Facts and Submissions of European Patent No. 3000448, dated Jul. 22, 2021, 46 pages. |
Summons to attend oral proceedings pursuant to Rule 115(1) EPC for European Patent No. 3254650, dated Jul. 19, 2021, 13 pages. |
Notice of Opposition—Opponents' Statement of Facts and Arguments of the European Patent No. 3360519, dated Aug. 12, 2021, 12 pages. |
Number | Date | Country | |
---|---|---|---|
20180243142 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14259026 | Apr 2014 | US |
Child | 15965734 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12744277 | US | |
Child | 14259026 | US |